þ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 |
¨ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 |
New York | 13-1432060 | |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
Large accelerated filer | þ | Accelerated filer | ¨ | |
Non-accelerated filer | ¨ | Smaller reporting company | ¨ | |
Emerging growth company | ¨ |
September 30, 2017 | December 31, 2016 | |||||||
ASSETS | ||||||||
Current Assets: | ||||||||
Cash and cash equivalents | $ | 316,002 | $ | 323,992 | ||||
Trade receivables (net of allowances of $14,258 and $9,995, respectively) | 691,239 | 550,658 | ||||||
Inventories: Raw materials | 303,296 | 288,629 | ||||||
Work in process | 15,724 | 13,792 | ||||||
Finished goods | 300,496 | 289,596 | ||||||
Total Inventories | 619,516 | 592,017 | ||||||
Prepaid expenses and other current assets | 222,990 | 142,347 | ||||||
Total Current Assets | 1,849,747 | 1,609,014 | ||||||
Property, plant and equipment, at cost | 2,073,149 | 1,913,333 | ||||||
Accumulated depreciation | (1,244,557 | ) | (1,137,617 | ) | ||||
828,592 | 775,716 | |||||||
Goodwill | 1,153,619 | 1,000,123 | ||||||
Other intangible assets, net | 424,138 | 365,783 | ||||||
Deferred income taxes | 158,094 | 138,636 | ||||||
Other assets | 106,248 | 127,712 | ||||||
Total Assets | $ | 4,520,438 | $ | 4,016,984 | ||||
LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||
Current Liabilities: | ||||||||
Bank borrowings and overdrafts and current portion of long-term debt | $ | 7,888 | $ | 258,516 | ||||
Commercial paper | 39,957 | — | ||||||
Accounts payable | 271,194 | 274,815 | ||||||
Accrued payroll and bonus | 74,488 | 64,357 | ||||||
Dividends payable | 54,440 | 50,678 | ||||||
Other current liabilities | 248,160 | 249,931 | ||||||
Total Current Liabilities | 696,127 | 898,297 | ||||||
Long-term debt | 1,625,502 | 1,066,855 | ||||||
Deferred gains | 37,975 | 39,816 | ||||||
Retirement liabilities | 241,563 | 243,407 | ||||||
Other liabilities | 156,783 | 137,475 | ||||||
Total Other Liabilities | 2,061,823 | 1,487,553 | ||||||
Commitments and Contingencies (Note 13) | ||||||||
Shareholders’ Equity: | ||||||||
Common stock 12 1/2¢ par value; authorized 500,000,000 shares; issued 115,858,190 shares as of September 30, 2017 and December 31, 2016 and outstanding 78,977,158 and 79,213,037 shares as of September 30, 2017 and December 31, 2016 | 14,470 | 14,470 | ||||||
Capital in excess of par value | 155,843 | 152,481 | ||||||
Retained earnings | 3,965,133 | 3,818,535 | ||||||
Accumulated other comprehensive loss | (656,651 | ) | (680,095 | ) | ||||
Treasury stock, at cost - 36,881,032 shares as of September 30, 2017 and 36,645,153 shares as of December 31, 2016 | (1,721,482 | ) | (1,679,147 | ) | ||||
Total Shareholders’ Equity | 1,757,313 | 1,626,244 | ||||||
Noncontrolling interest | 5,175 | 4,890 | ||||||
Total Shareholders’ Equity including noncontrolling interest | 1,762,488 | 1,631,134 | ||||||
Total Liabilities and Shareholders’ Equity | $ | 4,520,438 | $ | 4,016,984 |
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||
2017 | 2016 | 2017 | 2016 | ||||||||||||
Net sales | $ | 872,940 | $ | 777,001 | $ | 2,544,094 | $ | 2,353,790 | |||||||
Cost of goods sold | 490,884 | 430,733 | 1,422,783 | 1,281,673 | |||||||||||
Gross profit | 382,056 | 346,268 | 1,121,311 | 1,072,117 | |||||||||||
Research and development expenses | 70,932 | 64,415 | 210,963 | 191,052 | |||||||||||
Selling and administrative expenses | 141,473 | 152,046 | 417,713 | 408,372 | |||||||||||
Amortization of acquisition-related intangibles | 8,766 | 5,468 | 24,327 | 16,659 | |||||||||||
Restructuring and other charges, net | 3,249 | — | 14,183 | — | |||||||||||
Gain on sales of fixed assets | (31 | ) | (87 | ) | (120 | ) | (2,998 | ) | |||||||
Operating profit | 157,667 | 124,426 | 454,245 | 459,032 | |||||||||||
Interest expense | 19,221 | 13,111 | 49,584 | 40,649 | |||||||||||
Other (income) expense, net | (2,880 | ) | (2,075 | ) | (17,192 | ) | (1,954 | ) | |||||||
Income before taxes | 141,326 | 113,390 | 421,853 | 420,337 | |||||||||||
Taxes on income | 31,065 | 23,613 | 86,033 | 95,223 | |||||||||||
Net income | 110,261 | 89,777 | 335,820 | 325,114 | |||||||||||
Other comprehensive income (loss), after tax: | |||||||||||||||
Foreign currency translation adjustments | 19,719 | (6,191 | ) | 29,809 | 3,198 | ||||||||||
(Losses) gains on derivatives qualifying as hedges | (4,014 | ) | 268 | (17,533 | ) | (9,124 | ) | ||||||||
Pension and postretirement net liability | 3,845 | 2,586 | 11,168 | 7,719 | |||||||||||
Other comprehensive income (loss) | 19,550 | (3,337 | ) | 23,444 | 1,793 | ||||||||||
Total comprehensive income | $ | 129,811 | $ | 86,440 | $ | 359,264 | $ | 326,907 | |||||||
Net income per share - basic | $ | 1.39 | $ | 1.13 | $ | 4.24 | $ | 4.07 | |||||||
Net income per share - diluted | $ | 1.39 | $ | 1.12 | $ | 4.22 | $ | 4.05 | |||||||
Average number of shares outstanding - basic | 79,063 | 79,580 | 79,072 | 79,727 | |||||||||||
Average number of shares outstanding - diluted | 79,362 | 79,935 | 79,353 | 80,067 | |||||||||||
Dividends declared per share | $ | 0.69 | $ | 0.64 | $ | 1.97 | $ | 1.76 |
Nine Months Ended September 30, | ||||||||
2017 | 2016 | |||||||
Cash flows from operating activities: | ||||||||
Net income | $ | 335,820 | $ | 325,114 | ||||
Adjustments to reconcile to net cash provided by operating activities: | ||||||||
Depreciation and amortization | 85,446 | 75,109 | ||||||
Deferred income taxes | (3,439 | ) | 8,323 | |||||
Gain on disposal of assets | (120 | ) | (2,998 | ) | ||||
Stock-based compensation | 20,149 | 19,471 | ||||||
Pension contributions | (36,870 | ) | (44,356 | ) | ||||
Litigation settlement | (56,000 | ) | — | |||||
Foreign currency gain on liquidation of entity | (12,214 | ) | — | |||||
Changes in assets and liabilities, net of acquisitions: | ||||||||
Trade receivables | (94,945 | ) | (36,070 | ) | ||||
Inventories | 6,211 | (160 | ) | |||||
Accounts payable | (20,560 | ) | (29,523 | ) | ||||
Accruals for incentive compensation | 2,907 | 3,012 | ||||||
Other current payables and accrued expenses | 9,423 | 30,663 | ||||||
Other assets | 3,824 | (10,704 | ) | |||||
Other liabilities | (40,143 | ) | 3,956 | |||||
Net cash provided by operating activities | 199,489 | 341,837 | ||||||
Cash flows from investing activities: | ||||||||
Cash paid for acquisitions, net of cash received | (191,304 | ) | — | |||||
Additions to property, plant and equipment | (77,318 | ) | (70,179 | ) | ||||
Proceeds from life insurance contracts | 1,941 | 292 | ||||||
Maturity of net investment hedges | 2,226 | (12 | ) | |||||
Proceeds from disposal of assets | 1,275 | 3,664 | ||||||
Net cash used in investing activities | (263,180 | ) | (66,235 | ) | ||||
Cash flows from financing activities: | ||||||||
Cash dividends paid to shareholders | (151,678 | ) | (134,051 | ) | ||||
Decrease in revolving credit facility borrowings and overdrafts | (3,952 | ) | (128,324 | ) | ||||
Increase in commercial paper | 39,950 | — | ||||||
Deferred financing costs | (5,373 | ) | (4,780 | ) | ||||
Repayments of debt | (250,000 | ) | (125,000 | ) | ||||
Proceeds from issuance of long-term debt | 498,250 | 555,559 | ||||||
Loss on pre-issuance hedges | (5,310 | ) | (3,244 | ) | ||||
Proceeds from issuance of stock under stock plans | 329 | 594 | ||||||
Employee withholding taxes paid | (11,509 | ) | (13,315 | ) | ||||
Purchase of treasury stock | (53,211 | ) | (94,148 | ) | ||||
Net cash provided by financing activities | 57,496 | 53,291 | ||||||
Effect of exchange rate changes on cash and cash equivalents | (1,795 | ) | (12,151 | ) | ||||
Net change in cash and cash equivalents | (7,990 | ) | 316,742 | |||||
Cash and cash equivalents at beginning of year | 323,992 | 181,988 | ||||||
Cash and cash equivalents at end of period | $ | 316,002 | $ | 498,730 | ||||
Interest paid, net of amounts capitalized | $ | 38,634 | $ | 45,008 | ||||
Income taxes paid | $ | 77,356 | $ | 80,050 |
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||
(SHARES IN THOUSANDS) | 2017 | 2016 | 2017 | 2016 | |||||||
Basic | 79,063 | 79,580 | 79,072 | 79,727 | |||||||
Assumed dilution under stock plans | 299 | 355 | 281 | 340 | |||||||
Diluted | 79,362 | 79,935 | 79,353 | 80,067 |
(DOLLARS IN THOUSANDS) | Employee-Related Costs | Other | Total | ||||||||
Balance at December 31, 2016 | $ | 3,277 | $ | — | $ | 3,277 | |||||
Additional charges (reversals), net | 13,233 | 950 | 14,183 | ||||||||
Non-cash charges | — | (950 | ) | (950 | ) | ||||||
Payments | (10,267 | ) | — | (10,267 | ) | ||||||
Balance at September 30, 2017 | $ | 6,243 | $ | — | $ | 6,243 |
(DOLLARS IN THOUSANDS) | Goodwill | ||
Balance at December 31, 2016 | $ | 1,000,123 | |
Acquisitions | 93,223 | ||
Foreign exchange | 21,784 | ||
Other | 38,489 | ||
Balance at September 30, 2017 | $ | 1,153,619 |
September 30, | December 31, | ||||||
(DOLLARS IN THOUSANDS) | 2017 | 2016 | |||||
Cost | |||||||
Customer relationships | $ | 414,045 | $ | 371,270 | |||
Trade names & patents | 38,503 | 30,679 | |||||
Technological know-how | 153,410 | 119,544 | |||||
Other | 24,777 | 24,470 | |||||
Total carrying value | 630,735 | 545,963 | |||||
Accumulated Amortization | |||||||
Customer relationships | (99,300 | ) | (82,555 | ) | |||
Trade names & patents | (14,436 | ) | (12,198 | ) | |||
Technological know-how | (73,289 | ) | (68,292 | ) | |||
Other | (19,572 | ) | (17,135 | ) | |||
Total accumulated amortization | (206,597 | ) | (180,180 | ) | |||
Other intangible assets, net | $ | 424,138 | $ | 365,783 |
(DOLLARS IN THOUSANDS) | Rate | Maturities | September 30, 2017 | December 31, 2016 | ||||||||
Senior notes - 2007 (1) | 6.55 | % | 2019-27 | 249,765 | 499,676 | |||||||
Senior notes - 2013 (1) | 3.20 | % | 2023 | 298,594 | 297,986 | |||||||
Euro Senior notes - 2016 (1) | 1.75 | % | 2024 | 582,514 | 512,764 | |||||||
Senior notes - 2017 (1) | 4.38 | % | 2047 | 492,653 | — | |||||||
Commercial paper | 1.191 | % | 2017 | 39,957 | — | |||||||
Bank overdrafts and other | 9,807 | 13,599 | ||||||||||
Deferred realized gains on interest rate swaps | 57 | 1,346 | ||||||||||
1,673,347 | 1,325,371 | |||||||||||
Less: Current portion of debt | (47,845 | ) | (258,516 | ) | ||||||||
$ | 1,625,502 | $ | 1,066,855 |
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||
(DOLLARS IN THOUSANDS) | 2017 | 2016 | 2017 | 2016 | |||||||||||
Equity-based awards | $ | 7,256 | $ | 5,697 | $ | 20,149 | $ | 19,471 | |||||||
Liability-based awards | 1,396 | 1,836 | 4,447 | 4,168 | |||||||||||
Total stock-based compensation expense | 8,652 | 7,533 | 24,596 | 23,639 | |||||||||||
Less: tax benefit | (2,574 | ) | (2,174 | ) | (7,123 | ) | (6,963 | ) | |||||||
Total stock-based compensation expense, after tax | $ | 6,078 | $ | 5,359 | $ | 17,473 | $ | 16,676 |
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||
(DOLLARS IN THOUSANDS) | 2017 | 2016 | 2017 | 2016 | |||||||||||
Net sales: | |||||||||||||||
Flavors | $ | 409,800 | $ | 366,857 | $ | 1,230,286 | $ | 1,118,869 | |||||||
Fragrances | 463,140 | 410,144 | 1,313,808 | 1,234,921 | |||||||||||
Consolidated | $ | 872,940 | $ | 777,001 | $ | 2,544,094 | $ | 2,353,790 | |||||||
Segment profit: | |||||||||||||||
Flavors | $ | 91,378 | $ | 77,512 | $ | 289,723 | $ | 259,662 | |||||||
Fragrances | 93,528 | 85,010 | 260,085 | 261,843 | |||||||||||
Global expenses | (17,598 | ) | (11,405 | ) | (47,193 | ) | (37,544 | ) | |||||||
Restructuring and other charges, net (1) | (3,249 | ) | (190 | ) | (14,183 | ) | (473 | ) | |||||||
Acquisition-related costs (2) | (5,436 | ) | (786 | ) | (20,502 | ) | (2,035 | ) | |||||||
Operational improvement initiative costs (3) | (407 | ) | (802 | ) | (1,473 | ) | (1,901 | ) | |||||||
Legal (charges) credits (4) | — | (25,000 | ) | (1,000 | ) | (23,518 | ) | ||||||||
Gain on sales of assets (5) | 31 | 87 | 120 | 2,998 | |||||||||||
Tax assessment (6) | — | — | (5,331 | ) | — | ||||||||||
Integration-related costs (7) | (580 | ) | — | (2,501 | ) | — | |||||||||
FDA mandated product recall (8) | — | — | (3,500 | ) | — | ||||||||||
Operating profit | 157,667 | 124,426 | 454,245 | 459,032 | |||||||||||
Interest expense | (19,221 | ) | (13,111 | ) | (49,584 | ) | (40,649 | ) | |||||||
Other income (expense) | 2,880 | 2,075 | 17,192 | 1,954 | |||||||||||
Income before taxes | $ | 141,326 | $ | 113,390 | $ | 421,853 | $ | 420,337 |
(1) | In 2017, charges represent severance costs related to the 2017 Productivity Program. In 2016, charges relate to accelerated depreciation which were recorded in Cost of goods sold. |
(2) | Represents transaction costs related to the acquisitions of Fragrance Resources and PowderPure as well as the amortization of inventory "step-up" related to David Michael, Fragrance Resources and PowderPure in the 2017 period, and expense related to the amortization of inventory "step-up" and additional transaction costs related to the acquisition of Lucas Meyer in the 2016 period. |
(3) | Represents accelerated depreciation in Hangzhou, China in both the 2017 and 2016 periods. |
(4) | Represents additional charges related to litigation settlement in the 2017 period and reserve for litigation settlement in the 2016 period. |
(5) | Represents gains on sale of assets in Latin America in the 2017 period and in Europe in the 2016 period. |
(6) | Represents the reserve for a tax assessment related to commercial rent for prior periods. |
(7) | Represents costs related to the integration of the David Michael and Fragrance Resources acquisitions. |
(8) | Represents an estimate of the Company's incremental direct costs and customer reimbursement obligations, in excess of the Company's sales value of the recalled products, arising from an FDA mandated recall of consumer products as a result of raw material received and identified by the Company as containing contamination. (As discussed in Note 13, the sales value of the recalled products was reserved in the first quarter of 2017). While the Company does not believe that any of the affected raw material was included in its finished products delivered to the customer, as the delivered product included raw material of the same vendor lot that tested positive, the FDA, after being notified by the Company, initiated a recall of all consumer products including raw material from the affected vendor lot due to the potential for product contamination. |
U.S. Plans | Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||
(DOLLARS IN THOUSANDS) | 2017 | 2016 | 2017 | 2016 | |||||||||||
Service cost for benefits earned | $ | 698 | $ | 771 | $ | 2,093 | $ | 2,314 | |||||||
Interest cost on projected benefit obligation | 4,561 | 6,007 | 13,683 | 18,020 | |||||||||||
Expected return on plan assets | (9,246 | ) | (8,069 | ) | (27,737 | ) | (24,208 | ) | |||||||
Net amortization and deferrals | 1,793 | 1,387 | 5,377 | 4,159 | |||||||||||
Net periodic benefit (income) cost | (2,194 | ) | 96 | (6,584 | ) | 285 | |||||||||
Defined contribution and other retirement plans | 1,939 | 1,211 | 6,718 | 5,823 | |||||||||||
Total (income) expense | $ | (255 | ) | $ | 1,307 | $ | 134 | $ | 6,108 | ||||||
Non-U.S. Plans | Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||
(DOLLARS IN THOUSANDS) | 2017 | 2016 | 2017 | 2016 | |||||||||||
Service cost for benefits earned | $ | 5,956 | $ | 3,863 | $ | 17,867 | $ | 11,443 | |||||||
Interest cost on projected benefit obligation | 4,066 | 6,372 | 12,198 | 18,890 | |||||||||||
Expected return on plan assets | (12,873 | ) | (11,985 | ) | (38,618 | ) | (35,526 | ) | |||||||
Net amortization and deferrals | 4,185 | 3,286 | 12,554 | 9,738 | |||||||||||
Net periodic benefit cost | 1,334 | 1,536 | 4,001 | 4,545 | |||||||||||
Defined contribution and other retirement plans | 1,470 | 1,705 | 4,383 | 5,175 | |||||||||||
Total expense | $ | 2,804 | $ | 3,241 | $ | 8,384 | $ | 9,720 |
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||
(DOLLARS IN THOUSANDS) | 2017 | 2016 | 2017 | 2016 | |||||||||||
Service cost for benefits earned | $ | 221 | $ | 214 | $ | 663 | $ | 644 | |||||||
Interest cost on projected benefit obligation | 588 | 787 | 1,764 | 2,360 | |||||||||||
Net amortization and deferrals | (1,046 | ) | (1,355 | ) | (3,138 | ) | (4,065 | ) | |||||||
Total postretirement benefit income | $ | (237 | ) | $ | (354 | ) | $ | (711 | ) | $ | (1,061 | ) |
• | Level 1–Quoted prices for identical instruments in active markets. |
• | Level 2–Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets. |
• | Level 3–Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. |
September 30, 2017 | December 31, 2016 | ||||||||||||||
(DOLLARS IN THOUSANDS) | Carrying Amount | Fair Value | Carrying Amount | Fair Value | |||||||||||
Cash and cash equivalents (1) | $ | 316,002 | $ | 316,002 | $ | 323,992 | $ | 323,992 | |||||||
Credit facilities and bank overdrafts (2) | 9,807 | 9,807 | 13,599 | 13,599 | |||||||||||
Commercial paper (2) | 39,957 | 39,957 | — | — | |||||||||||
Long-term debt: (3) | |||||||||||||||
Senior notes - 2007 | 249,765 | 297,010 | 499,676 | 556,222 | |||||||||||
Senior notes - 2013 | 298,594 | 307,675 | 297,986 | 302,376 | |||||||||||
Euro Senior notes - 2016 | 582,514 | 614,498 | 512,764 | 546,006 | |||||||||||
Senior notes - 2017 | 492,653 | 497,998 | — | — |
(1) | The carrying amount of cash and cash equivalents approximates fair value due to the short maturity of those instruments. |
(2) | The carrying amount of our credit facilities, bank overdrafts and commercial paper approximates fair value as the interest rate is reset frequently based on current market rates as well as the short maturity of those instruments. |
(3) | The fair value of our long-term debt was calculated using discounted cash flows applying current interest rates and current credit spreads based on our own credit risk. |
(DOLLARS IN THOUSANDS) | September 30, 2017 | December 31, 2016 | |||||
Foreign currency contracts | $ | 756,631 | $ | 527,500 | |||
Interest rate swaps | 150,000 | 412,500 |
September 30, 2017 | |||||||||||
(DOLLARS IN THOUSANDS) | Fair Value of Derivatives Designated as Hedging Instruments | Fair Value of Derivatives Not Designated as Hedging Instruments | Total Fair Value | ||||||||
Derivative assets (a) | |||||||||||
Foreign currency contracts | $ | 1,171 | $ | 14,335 | $ | 15,506 | |||||
$ | 1,171 | $ | 14,335 | $ | 15,506 | ||||||
Derivative liabilities (b) | |||||||||||
Foreign currency contracts | $ | 9,942 | $ | 2,016 | $ | 11,958 | |||||
Interest rate swaps | 604 | — | 604 | ||||||||
$ | 10,546 | $ | 2,016 | $ | 12,562 |
December 31, 2016 | |||||||||||
(DOLLARS IN THOUSANDS) | Fair Value of Derivatives Designated as Hedging Instruments | Fair Value of Derivatives Not Designated as Hedging Instruments | Total Fair Value | ||||||||
Derivative assets (a) | |||||||||||
Foreign currency contracts | $ | 13,765 | $ | 7,737 | $ | 21,502 | |||||
Interest rate swaps | 335 | — | 335 | ||||||||
$ | 14,100 | $ | 7,737 | $ | 21,837 | ||||||
Derivative liabilities (b) | |||||||||||
Foreign currency contracts | $ | 46 | $ | 2,209 | $ | 2,255 | |||||
Interest rate swaps | 725 | — | 725 | ||||||||
$ | 771 | $ | 2,209 | $ | 2,980 |
(a) | Derivative assets are recorded to Prepaid expenses and other current assets in the Consolidated Balance Sheet. |
(b) | Derivative liabilities are recorded as Other current liabilities in the Consolidated Balance Sheet. |
Derivatives Not Designated as Hedging Instruments | Amount of Gain (Loss) Recognized in Income on Derivative | Location of Gain (Loss) Recognized in Income on Derivative | |||||||
Three Months Ended September 30, | |||||||||
2017 | 2016 | ||||||||
Foreign currency contracts | $ | 4,024 | $ | (3,313 | ) | Other (income) expense, net | |||
Derivatives Not Designated as Hedging Instruments | Amount of Gain (Loss) Recognized in Income on Derivative | Location of Gain (Loss) Recognized in Income on Derivative | |||||||
Nine Months Ended September 30, | |||||||||
2017 | 2016 | ||||||||
Foreign currency contracts | $ | (9,157 | ) | $ | (6,860 | ) | Other (income) expense, net |
Amount of (Loss) Gain Recognized in OCI on Derivative (Effective Portion) | Location of (Loss) Gain Reclassified from AOCI into Income (Effective Portion) | Amount of (Loss) Gain Reclassified from Accumulated OCI into Income (Effective Portion) | |||||||||||||||
Three Months Ended September 30, | Three Months Ended September 30, | ||||||||||||||||
2017 | 2016 | 2017 | 2016 | ||||||||||||||
Derivatives in Cash Flow Hedging Relationships: | |||||||||||||||||
Foreign currency contracts | $ | (4,229 | ) | $ | 98 | Cost of goods sold | $ | 1,815 | $ | (544 | ) | ||||||
Interest rate swaps (1) | 216 | 171 | Interest expense | (216 | ) | (171 | ) | ||||||||||
Derivatives in Net Investment Hedging Relationships: | |||||||||||||||||
Foreign currency contracts | (1,130 | ) | (224 | ) | N/A | — | — | ||||||||||
Euro Senior notes - 2016 | (11,861 | ) | (2,856 | ) | N/A | — | — | ||||||||||
Total | $ | (17,004 | ) | $ | (2,811 | ) | $ | 1,599 | $ | (715 | ) | ||||||
Amount of (Loss) Gain Recognized in OCI on Derivative (Effective Portion) | Location of (Loss) Gain Reclassified from AOCI into Income (Effective Portion) | Amount of (Loss) Gain Reclassified from Accumulated OCI into Income (Effective Portion) | |||||||||||||||
Nine Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||
2017 | 2016 | 2017 | 2016 | ||||||||||||||
Derivatives in Cash Flow Hedging Relationships: | |||||||||||||||||
Foreign currency contracts | $ | (13,505 | ) | $ | (6,293 | ) | Cost of goods sold | $ | 4,062 | $ | 4,808 | ||||||
Interest rate swaps (1) | (4,027 | ) | (2,830 | ) | Interest expense | (573 | ) | (428 | ) | ||||||||
Derivatives in Net Investment Hedging Relationships: | |||||||||||||||||
Foreign currency contracts | (4,258 | ) | (694 | ) | N/A | — | — | ||||||||||
Euro Senior notes - 2016 | (43,050 | ) | 6,793 | N/A | — | — | |||||||||||
Total | $ | (64,840 | ) | $ | (3,024 | ) | $ | 3,489 | $ | 4,380 |
Foreign Currency Translation Adjustments | (Losses) Gains on Derivatives Qualifying as Hedges | Pension and Postretirement Liability Adjustment | Total | ||||||||||||
(DOLLARS IN THOUSANDS) | |||||||||||||||
Accumulated other comprehensive (loss) income, net of tax, as of December 31, 2016 | $ | (352,025 | ) | $ | 7,604 | $ | (335,674 | ) | $ | (680,095 | ) | ||||
OCI before reclassifications | 42,023 | (14,044 | ) | — | 27,979 | ||||||||||
Amounts reclassified from AOCI | (12,214 | ) | * | (3,489 | ) | 11,168 | (4,535 | ) | |||||||
Net current period other comprehensive income (loss) | 29,809 | (17,533 | ) | 11,168 | 23,444 | ||||||||||
Accumulated other comprehensive (loss) income, net of tax, as of September 30, 2017 | $ | (322,216 | ) | $ | (9,929 | ) | $ | (324,506 | ) | $ | (656,651 | ) |
Foreign Currency Translation Adjustments | (Losses) Gains on Derivatives Qualifying as Hedges | Pension and Postretirement Liability Adjustment | Total | ||||||||||||
(DOLLARS IN THOUSANDS) | |||||||||||||||
Accumulated other comprehensive (loss) income, net of tax, as of December 31, 2015 | $ | (297,499 | ) | $ | 9,401 | $ | (325,342 | ) | $ | (613,440 | ) | ||||
OCI before reclassifications | 3,198 | (4,744 | ) | — | (1,546 | ) | |||||||||
Amounts reclassified from AOCI | — | (4,380 | ) | 7,719 | 3,339 | ||||||||||
Net current period other comprehensive income (loss) | 3,198 | (9,124 | ) | 7,719 | 1,793 | ||||||||||
Accumulated other comprehensive (loss) income, net of tax, as of September 30, 2016 | $ | (294,301 | ) | $ | 277 | $ | (317,623 | ) | $ | (611,647 | ) |
Nine Months Ended September 30, 2017 | Nine Months Ended September 30, 2016 | Affected Line Item in the Consolidated Statement of Comprehensive Income | |||||||
(DOLLARS IN THOUSANDS) | |||||||||
(Losses) gains on derivatives qualifying as hedges | |||||||||
Foreign currency contracts | $ | 4,642 | $ | 5,495 | Cost of goods sold | ||||
Interest rate swaps | (573 | ) | (428 | ) | Interest expense | ||||
(580 | ) | (687 | ) | Provision for income taxes | |||||
$ | 3,489 | $ | 4,380 | Total, net of income taxes | |||||
(Losses) gains on pension and postretirement liability adjustments | |||||||||
Prior service cost | $ | 5,304 | $ | 5,602 | (a) | ||||
Actuarial losses | (20,097 | ) | (15,434 | ) | (a) | ||||
3,625 | 2,113 | Provision for income taxes | |||||||
$ | (11,168 | ) | $ | (7,719 | ) | Total, net of income taxes |
(a) | The amortization of prior service cost and actuarial loss is included in the computation of net periodic benefit cost. Refer to Note 14 of our 2016 Form 10-K for additional information regarding net periodic benefit cost. |
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||
(DOLLARS IN THOUSANDS EXCEPT PER SHARE AMOUNTS) | 2017 | 2016 | Change | 2017 | 2016 | Change | |||||||||||||||
Net sales | $ | 872,940 | $ | 777,001 | 12 | % | $ | 2,544,094 | $ | 2,353,790 | 8 | % | |||||||||
Cost of goods sold | 490,884 | 430,733 | 14 | % | 1,422,783 | 1,281,673 | 11 | % | |||||||||||||
Gross profit | 382,056 | 346,268 | 1,121,311 | 1,072,117 | |||||||||||||||||
Research and development (R&D) expenses | 70,932 | 64,415 | 10 | % | 210,963 | 191,052 | 10 | % | |||||||||||||
Selling and administrative (S&A) expenses | 141,473 | 152,046 | (7 | )% | 417,713 | 408,372 | 2 | % | |||||||||||||
Amortization of acquisition-related intangibles | 8,766 | 5,468 | 60 | % | 24,327 | 16,659 | 46 | % | |||||||||||||
Restructuring and other charges, net | 3,249 | — | 100 | % | 14,183 | — | 100 | % | |||||||||||||
Gain on sales of fixed assets | (31 | ) | (87 | ) | (64 | )% | (120 | ) | (2,998 | ) | (96 | )% | |||||||||
Operating profit | 157,667 | 124,426 | 454,245 | 459,032 | |||||||||||||||||
Interest expense | 19,221 | 13,111 | 47 | % | 49,584 | 40,649 | 22 | % | |||||||||||||
Other (income) expense, net | (2,880 | ) | (2,075 | ) | 39 | % | (17,192 | ) | (1,954 | ) | 780 | % | |||||||||
Income before taxes | 141,326 | 113,390 | 421,853 | 420,337 | |||||||||||||||||
Taxes on income | 31,065 | 23,613 | 32 | % | 86,033 | 95,223 | (10 | )% | |||||||||||||
Net income | $ | 110,261 | $ | 89,777 | 23 | % | $ | 335,820 | $ | 325,114 | 3 | % | |||||||||
Diluted EPS | $ | 1.39 | $ | 1.12 | 24 | % | $ | 4.22 | $ | 4.05 | 4 | % | |||||||||
Gross margin | 43.8 | % | 44.6 | % | (80 | ) | 44.1 | % | 45.5 | % | (140 | ) | |||||||||
R&D as a percentage of sales | 8.1 | % | 8.3 | % | (20 | ) | 8.3 | % | 8.1 | % | 20 | ||||||||||
S&A as a percentage of sales | 16.2 | % | 19.6 | % | (340 | ) | 16.4 | % | 17.3 | % | (90 | ) | |||||||||
Operating margin | 18.1 | % | 16.0 | % | 210 | 17.9 | % | 19.5 | % | (160 | ) | ||||||||||
Adjusted operating margin (1) | 19.2 | % | 19.4 | % | (20 | ) | 19.8 | % | 20.6 | % | (80 | ) | |||||||||
Effective tax rate | 22.0 | % | 20.8 | % | 120 | 20.4 | % | 22.7 | % | (230 | ) | ||||||||||
Segment net sales | |||||||||||||||||||||
Flavors | $ | 409,800 | $ | 366,857 | 12 | % | $ | 1,230,286 | $ | 1,118,869 | 10 | % | |||||||||
Fragrances | 463,140 | 410,144 | 13 | % | 1,313,808 | 1,234,921 | 6 | % | |||||||||||||
Consolidated | $ | 872,940 | $ | 777,001 | $ | 2,544,094 | $ | 2,353,790 |
(1) | Adjusted operating margin excludes $9.6 million consisting of acquisition-related costs, restructuring, integration-related and operational improvement initiative costs as well as gains on sales of fixed assets for the three months ended September 30, 2017 and excludes $26.7 million related to legal charges, operational improvement initiative, acquisition-relation and restructuring costs which were partially offset by gains on sales of fixed assets for the three months ended September 30, 2016. For the nine months ended September 30, 2017 adjusted operating margin excludes $48.4 million consisting of acquisition-related costs, costs associated with product recalls, tax assessment, legal charges, restructuring, integration-related and operational improvement initiative costs as well as gains on sales of fixed assets and excludes $24.9 million related to legal charges, operational improvement initiative, acquisition-relation and restructuring costs which were partially offset by gains on sales of fixed assets for the nine months ended September 30, 2016. See "Non-GAAP Financial Measures" below. |
% Change in Sales - Third Quarter 2017 vs. Third Quarter 2016 | ||||||||||||||||||
Fine Fragrances | Consumer Fragrances | Ingredients | Total Frag. | Flavors | Total | |||||||||||||
NOAM | Reported | 12 | % | 10 | % | -4 | % | 7 | % | 28 | % | 18 | % | |||||
EAME | Reported | 28 | % | 17 | % | 18 | % | 20 | % | 12 | % | 17 | % | |||||
Currency Neutral (1) | 25 | % | 14 | % | 16 | % | 18 | % | 12 | % | 15 | % | ||||||
LA | Reported | 14 | % | 13 | % | 37 | % | 15 | % | 0 | % | 9 | % | |||||
Currency Neutral (1) | 10 | % | 13 | % | 37 | % | 14 | % | 1 | % | 9 | % | ||||||
GA | Reported | 13 | % | 8 | % | -1 | % | 6 | % | 2 | % | 4 | % | |||||
Currency Neutral (1) | 14 | % | 8 | % | 0 | % | 7 | % | 2 | % | 4 | % | ||||||
Total | Reported | 20 | % | 12 | % | 9 | % | 13 | % | 12 | % | 12 | % | |||||
Currency Neutral (1) | 18 | % | 11 | % | 8 | % | 12 | % | 12 | % | 12 | % |
(1) | Currency neutral sales growth is calculated by translating prior year sales at the exchange rates for the corresponding 2017 period. |
• | NOAM Flavors sales growth included the impact of acquisitions and primarily reflected double-digit growth in Savory and low single-digit growth in Beverage, which more than offset mid to high single-digit declines in Sweet and Dairy categories. Total Fragrances sales growth included the impact of acquisitions and reflected double-digit gains in Fine Fragrances and high single-digit gains in Fabric Care and Home Care which more than offset double-digit declines in Personal Wash and mid single-digit declines in Fragrance Ingredients. |
• | EAME Flavors sales experienced double-digit gains in Beverage and Dairy and mid single-digit gains in Savory and Sweet. Total Fragrances sales growth included the impact of acquisitions and was driven mainly by double-digit growth in Fine Fragrances, Home Care and Fragrance Ingredients as well as mid single-digit growth in Fabric Care which more than offset high single-digit declines in Hair Care and low single-digit declines in Personal Wash and Toiletries. |
• | LA Flavors sales included double-digit gains in Dairy and high single-digit gains in Savory which were offset by low single-digit declines in Beverage. Total Fragrances sales growth included the impact of acquisitions and reflected double-digit gains in Fragrance Ingredients, Home Care, Personal Wash and Fine Fragrances as well as high single-digit gains in Fabric Care. |
• | GA Flavors sales growth was driven by mid to high single-digit growth in Savory and Sweet, which were only partially offset by mid to low single-digit declines in Beverage and Dairy. Total Fragrances sales growth included the impact of acquisitions and was principally driven by double-digit gains in Fine Fragrances, Fabric Care and Home Care and high single-digit gains in Toiletries, which more than offset mid single-digit declines in Hair Care and low single-digit declines in Fragrance Ingredients. |
Three Months Ended September 30, | |||||||
(DOLLARS IN THOUSANDS) | 2017 | 2016 | |||||
Segment profit: | |||||||
Flavors | $ | 91,378 | $ | 77,512 | |||
Fragrances | 93,528 | 85,010 | |||||
Global expenses | (17,598 | ) | (11,405 | ) | |||
Restructuring and other charges, net | (3,249 | ) | (190 | ) | |||
Acquisition and related costs | (5,436 | ) | (786 | ) | |||
Operational improvement initiative costs | (407 | ) | (802 | ) | |||
Legal (charges) credits | — | (25,000 | ) | ||||
Gain on sales of assets | 31 | 87 | |||||
Integration-related costs | (580 | ) | — | ||||
Operating profit | 157,667 | 124,426 | |||||
Profit margin: | |||||||
Flavors | 22.3 | % | 21.1 | % | |||
Fragrances | 20.2 | % | 20.7 | % | |||
Consolidated | 18.1 | % | 16.0 | % |
% Change in Sales - First Nine Months 2017 vs. First Nine Months 2016 | ||||||||||||||||||
Fine Fragrances | Consumer Fragrances | Ingredients | Total Frag. | Flavors | Total | |||||||||||||
NOAM | Reported | 11 | % | 7 | % | -4 | % | 5 | % | 28 | % | 17 | % | |||||
EAME | Reported | 21 | % | 9 | % | 12 | % | 13 | % | 5 | % | 10 | % | |||||
Currency Neutral (1) | 22 | % | 10 | % | 13 | % | 14 | % | 9 | % | 12 | % | ||||||
LA | Reported | -1 | % | -1 | % | 30 | % | 1 | % | 7 | % | 3 | % | |||||
Currency Neutral (1) | -5 | % | -1 | % | 29 | % | 0 | % | 6 | % | 2 | % | ||||||
GA | Reported | 19 | % | 3 | % | -4 | % | 2 | % | 0 | % | 1 | % | |||||
Currency Neutral (1) | 20 | % | 3 | % | -3 | % | 3 | % | 1 | % | 2 | % | ||||||
Total | Reported | 13 | % | 4 | % | 5 | % | 6 | % | 10 | % | 8 | % | |||||
Currency Neutral (1) | 13 | % | 5 | % | 6 | % | 7 | % | 11 | % | 9 | % |
(1) | Currency neutral sales growth is calculated by translating prior year sales at the exchange rates for the corresponding 2017 period. |
• | NOAM Flavors sales growth, which included the impact of acquisitions, was led by double-digit growth in Savory and mid single-digit growth in Dairy. Total Fragrances sales growth included the impact of acquisitions and reflected double-digit gains in Fine Fragrances, mid to high single-digit gains in Home Care and Fabric Care which more than offset double-digit declines in Personal Wash, high single-digit declines in Hair Care and mid single-digit declines in Fragrance Ingredients. |
• | EAME Flavors sales experienced mid to high single-digit gains in all categories. Total Fragrances sales growth included the impact of acquisitions and was driven mainly by double-digit growth in Fine Fragrances and Fragrance Ingredients as well as mid single-digit growth in Home Care. |
• | LA Flavors sales growth was driven by double-digit gains in Savory and Dairy and mid to low single-digit gains in Sweet and Beverage. Total Fragrances sales growth reflected double-digit gains in Fragrance Ingredients and mid single-digit gains in Home Care, which more than offset by double-digit declines in Hair Care and low single-digit declines in Fine Fragrances. |
• | GA Flavors sales experienced low single-digit gains in Savory and Beverage which were offset by mid single-digit declines in Dairy. Total Fragrances sales growth included the impact of acquisitions and principally reflected double-digit gains in Fine Fragrances and mid single-digit gains in Fabric Care and Home Care, which more than offset mid single-digit declines in Fragrance Ingredients and Hair Care. |
Nine Months Ended September 30, | |||||||
(DOLLARS IN THOUSANDS) | 2017 | 2016 | |||||
Segment profit: | |||||||
Flavors | $ | 289,723 | $ | 259,662 | |||
Fragrances | 260,085 | 261,843 | |||||
Global expenses | (47,193 | ) | (37,544 | ) | |||
Restructuring and other charges, net | (14,183 | ) | (473 | ) | |||
Acquisition and related costs | (20,502 | ) | (2,035 | ) | |||
Operational improvement initiative costs | (1,473 | ) | (1,901 | ) | |||
Legal (charges) credits | (1,000 | ) | (23,518 | ) | |||
Gain on sales of assets | 120 | 2,998 | |||||
Tax assessment | (5,331 | ) | — | ||||
Integration-related costs | (2,501 | ) | — | ||||
FDA mandated product recall | (3,500 | ) | — | ||||
Operating profit | 454,245 | 459,032 | |||||
Profit margin: | |||||||
Flavors | 23.5 | % | 23.2 | % | |||
Fragrances | 19.8 | % | 21.2 | % | |||
Consolidated | 17.9 | % | 19.5 | % |
(1) | Adjusted EBITDA and Net Debt, which are non-GAAP measures used for these covenants, are calculated in accordance with the definition in the debt agreements. In this context, these measures are used solely to provide information on the extent to which we are in compliance with debt covenants and may not be comparable to adjusted EBITDA and Net Debt used by other companies. Reconciliations of adjusted EBITDA to net income and net debt to total debt are as follows: |
Twelve Months Ended September 30, | |||
(DOLLARS IN MILLIONS) | 2017 | ||
Net income | $ | 415.8 | |
Interest expense | 61.9 | ||
Income taxes | 109.5 | ||
Depreciation and amortization | 112.5 | ||
Specified items (1) | 71.8 | ||
Non-cash items (2) | 17.3 | ||
Adjusted EBITDA | $ | 788.8 |
(1) | Specified items for the 12 months ended September 30, 2017 of $71.8 million consist of legal charges/credits, acquisition-related costs, costs associated with product recalls, operational improvement initiative costs, restructuring and other charges, gains on sales of fixed assets, integration-related costs, tax assessment and CTA realization. |
(2) | Non-cash items represent all other adjustments to reconcile net income to net cash provided by operations as presented on the Statement of Cash Flows, including gain on disposal of assets and stock-based compensation. |
September 30, | |||
(DOLLARS IN MILLIONS) | 2017 | ||
Total debt | $ | 1,673.3 | |
Adjustments: | |||
Deferred gain on interest rate swaps | (0.1 | ) | |
Cash and cash equivalents | (316.0 | ) | |
Net debt | $ | 1,357.2 |
• | macroeconomic trends affecting the emerging markets; |
• | our ability to implement and adapt our Vision 2020 strategy; |
• | our ability to successfully identify and complete acquisitions in line with our Vision 2020 strategy, and to realize the anticipated benefits of those acquisitions; |
• | our ability to effectively compete in our market, and to successfully develop new and competitive products that appeal to our customers and consumers; |
• | changes in consumer preferences and demand for our products or a decline in consumer confidence and spending; |
• | our ability to benefit from our investments and expansion in emerging markets; |
• | the impact of currency fluctuations or devaluations in the principal foreign markets in which we operate, including the devaluation of the Euro; |
• | the impact of customer claims or product recalls; |
• | the potential adverse impact of Brexit on currency exchange rates, global economic conditions and cross-border agreements that affect our business; |
• | the economic and political risks associated with our international operations, including challenging economic conditions in China and Latin America; |
• | the impact of any failure of our key information technology systems or costs that could be incurred due to a breach of data privacy or information security; |
• | our ability to attract and retain talented employees; |
• | our ability to comply with, and the costs associated with compliance, with U.S. and foreign environmental protection laws; |
• | our ability to realize expected cost savings and efficiencies from our profitability improvement initiatives and other optimization activities; |
• | volatility and increases in the price of raw materials, energy and transportation; |
• | fluctuations in the quality and availability of raw materials; |
• | the impact of a disruption in our supply chain or our relationship with our suppliers; |
• | any adverse impact on the availability, effectiveness and cost of our hedging and risk management strategies; |
• | our ability to successfully manage our working capital and inventory balances; |
• | uncertainties regarding the outcome of, or funding requirements, related to litigation or settlement of pending litigation, uncertain tax positions or other contingencies; |
• | the effect of legal and regulatory proceedings, as well as restrictions imposed on us, our operations, or our representatives by U.S. and foreign governments; |
• | adverse changes in federal, state, local and international tax legislation or policies, including with respect to transfer pricing and state aid, and adverse results of tax audits, assessments, or disputes; and |
• | changes in market conditions or governmental regulations relating to our pension and postretirement obligations. |
(DOLLARS IN THOUSANDS) | Reconciliation of Gross Profit | |||||||||||
Reported (GAAP) | Operational Improvement Initiative Costs (a) | Acquisition and Related Costs (b) | Integration related costs (c) | Adjusted (Non-GAAP) | ||||||||
Gross profit | $ | 382,056 | 407 | 5,147 | 131 | $ | 387,741 |
(DOLLARS IN THOUSANDS) | Reconciliation of Selling and Administrative Expenses | |||||||||
Reported (GAAP) | Acquisition and Related Costs (b) | Integration related costs (c) | Adjusted (Non-GAAP) | |||||||
Selling and administrative expenses | $ | 141,473 | (289 | ) | (383 | ) | $ | 140,801 |
(DOLLARS IN THOUSANDS) | Reconciliation of Operating Profit | |||||||||||||||
Reported (GAAP) | Operational Improvement Initiative Costs (a) | Acquisition Related Costs (b) | Integration related costs (c) | Restructuring and Other Charges (d) | Gain on Sale of Asset (e) | Adjusted (Non-GAAP) | ||||||||||
Operating profit | $ | 157,667 | 407 | 5,436 | 580 | 3,249 | (31 | ) | $ | 167,308 |
(DOLLARS IN THOUSANDS) | Reconciliation of Net Income | |||||||||||||||
Reported (GAAP) | Operational Improvement Initiative Costs (a) | Acquisition Related Costs (b) | Integration related costs (c) | Restructuring and Other Charges (d) | Gain on Sale of Asset (e) | Adjusted (Non-GAAP) | ||||||||||
Income before taxes | $ | 141,326 | 407 | 5,436 | 580 | 3,249 | (31 | ) | $ | 150,967 | ||||||
Taxes on income (f) | $ | 31,065 | 102 | 1,949 | 152 | 1,012 | (10 | ) | $ | 34,270 | ||||||
Net income | $ | 110,261 | 305 | 3,487 | 428 | 2,237 | (21 | ) | $ | 116,697 |
(DOLLARS IN THOUSANDS) | Reconciliation of Gross Profit | ||||||||
Reported (GAAP) | Restructuring and Other Charges (a) | Operational Improvement Initiative Costs (b) | Adjusted (Non-GAAP) | ||||||
Gross profit | $ | 346,268 | 190 | 791 | 347,249 |
(DOLLARS IN THOUSANDS) | Reconciliation of Selling and Administrative Expenses | ||||||||||
Reported (GAAP) | Operational Improvement Initiative Costs (b) | Acquisition and Related Costs (c) | Legal Charges/Credits (d) | Adjusted (Non-GAAP) | |||||||
Selling and administrative expenses | $ | 152,046 | (11 | ) | (786 | ) | (25,000 | ) | 126,249 |
(DOLLARS IN THOUSANDS) | Reconciliation of Operating Profit | ||||||||||||||
Reported (GAAP) | Restructuring and Other Charges (a) | Operational Improvement Initiative Costs (b) | Acquisition Related Costs (c) | Legal Charges/Credits (d) | Gain on Sale of Asset (e) | Adjusted (Non-GAAP) | |||||||||
Operating profit | $ | 124,426 | 190 | 802 | 786 | 25,000 | (87 | ) | 151,117 |
(DOLLARS IN THOUSANDS) | Reconciliation of Net Income | |||||||||||||||
Reported (GAAP) | Restructuring and Other Charges (a) | Operational Improvement Initiative Costs (b) | Acquisition Related Costs (c) | Legal Charges/Credits (d) | Gain on Sale of Asset (e) | Adjusted (Non-GAAP) | ||||||||||
Income before taxes | $ | 113,390 | 190 | 802 | 786 | 25,000 | (87 | ) | $ | 140,081 | ||||||
Taxes on income (f) | $ | 23,613 | 36 | 200 | 276 | 8,750 | (29 | ) | $ | 32,846 | ||||||
Net income | $ | 89,777 | 154 | 602 | 510 | 16,250 | (58 | ) | $ | 107,235 |
(DOLLARS IN THOUSANDS) | Reconciliation of Gross Profit | |||||||||||||
Reported (GAAP) | Operational Improvement Initiative Costs (a) | Acquisition and Related Costs (b) | Integration related costs (c) | FDA mandated product recall (i) | Adjusted (Non-GAAP) | |||||||||
Gross profit | $ | 1,121,311 | 1,473 | 16,055 | 316 | 3,500 | $ | 1,142,655 |
(DOLLARS IN THOUSANDS) | Reconciliation of Selling and Administrative Expenses | |||||||||||||
Reported (GAAP) | Acquisition and Related Costs (b) | Integration related costs (c) | Legal Charges/Credits (d) | Tax Assessment (e) | Adjusted (Non-GAAP) | |||||||||
Selling and administrative expenses | $ | 417,713 | (4,447 | ) | (1,867 | ) | (1,000 | ) | (5,331 | ) | $ | 405,068 |
(DOLLARS IN THOUSANDS) | Reconciliation of Operating Profit | |||||||||||||||||||||
Reported (GAAP) | Operational Improvement Initiative Costs (a) | Acquisition Related Costs (b) | Integration related costs (c) | Legal Charges/Credits (d) | Tax Assessment (e) | Restructuring and Other Charges (f) | Gain on Sale of Asset (g) | FDA mandated product recall (i) | Adjusted (Non-GAAP) | |||||||||||||
Operating profit | $ | 454,245 | 1,473 | 20,502 | 2,501 | 1,000 | 5,331 | 14,183 | (120 | ) | 3,500 | $ | 502,615 |
(DOLLARS IN THOUSANDS) | Reconciliation of Net Income | |||||||||||||||||||||||
Reported (GAAP) | Operational Improvement Initiative Costs (a) | Acquisition Related Costs (b) | Integration related costs (c) | Legal Charges/Credits (d) | Tax Assessment (e) | Restructuring and Other Charges (f) | Gain on Sale of Asset (g) | CTA Realization (h) | FDA mandated product recall (i) | Adjusted (Non-GAAP) | ||||||||||||||
Income before taxes | $ | 421,853 | 1,473 | 20,502 | 2,501 | 1,000 | 5,331 | 14,183 | (120 | ) | (12,217 | ) | 3,500 | $ | 458,006 | |||||||||
Taxes on income (j) | $ | 86,033 | 368 | 6,559 | 757 | 354 | 1,885 | 3,904 | (39 | ) | — | 1,238 | $ | 101,059 | ||||||||||
Net income | $ | 335,820 | 1,105 | 13,943 | 1,744 | 646 | 3,446 | 10,279 | (81 | ) | (12,217 | ) | 2,262 | $ | 356,947 |
(DOLLARS IN THOUSANDS) | Reconciliation of Gross Profit | ||||||||||
Reported (GAAP) | Restructuring and Other Charges (a) | Operational Improvement Initiative Costs (b) | Acquisition and Related Costs (c) | Adjusted (Non-GAAP) | |||||||
Gross profit | $ | 1,072,117 | 473 | 1,890 | 889 | 1,075,369 |
(DOLLARS IN THOUSANDS) | Reconciliation of Selling and Administrative Expenses | |||||||||||
Reported (GAAP) | Operational Improvement Initiative Costs (b) | Acquisition and Related Costs (c) | Legal Charges/Credits (d) | Adjusted (Non-GAAP) | ||||||||
Selling and Administrative Expenses | $ | 408,372 | (11 | ) | (1,146 | ) | (23,518 | ) | $ | 383,697 |
(DOLLARS IN THOUSANDS) | Reconciliation of Operating Profit | ||||||||||||||
Reported (GAAP) | Restructuring and Other Charges (a) | Operational Improvement Initiative Costs (b) | Acquisition Related Costs (c) | Legal Charges/Credits (d) | Gain on Sale of Asset (e) | Adjusted (Non-GAAP) | |||||||||
Operating profit | $ | 459,032 | 473 | 1,901 | 2,035 | 23,518 | (2,998 | ) | 483,961 |
(DOLLARS IN THOUSANDS) | Reconciliation of Net Income | |||||||||||||||
Reported (GAAP) | Restructuring and Other Charges (a) | Operational Improvement Initiative Costs (b) | Acquisition Related Costs (c) | Legal Charges/Credits (d) | Gain on Sale of Asset (e) | Adjusted (Non-GAAP) | ||||||||||
Income before taxes | $ | 420,337 | 473 | 1,901 | 2,035 | 23,518 | (2,998 | ) | $ | 445,266 | ||||||
Taxes on income (f) | $ | 95,223 | 90 | 475 | 542 | 8,339 | (666 | ) | $ | 104,003 | ||||||
Net income | $ | 325,114 | 383 | 1,426 | 1,493 | 15,179 | (2,332 | ) | $ | 341,263 |
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||
2017 | 2016 | 2017 | 2016 | ||||
Operating Profit: | |||||||
% Change - Reported (GAAP) | 27% | (21)% | (1)% | (2)% | |||
Items impacting comparability (1) | (16)% | 13% | 5% | 3% | |||
% Change - Adjusted (Non-GAAP) | 11% | (8)% | 4% | —% | |||
Currency Impact | (4)% | 4% | 2% | 3% | |||
% Change Year-over-Year - Currency Neutral Adjusted (Non-GAAP)** | 7% | (4)% | 5% | * | 3% |
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||
(DOLLARS IN MILLIONS) | 2017 | 2016 | 2017 | 2016 | |||
Amortization Expense: | |||||||
PowderPure | $0.6 | $— | $1.2 | $— | |||
Fragrance Resources | 1.6 | — | 4.4 | — | |||
David Michael | 1.1 | — | 2.9 | — | |||
Lucas Meyer | 2.0 | 2.0 | 5.8 | 6.3 | |||
Ottens Flavors | 1.6 | 1.6 | 4.7 | 4.8 |
3(ii) | Bylaws of International Flavors & Fragrances Inc., effective as of August 1, 2017, incorporated by reference to Exhibit 3(ii) to the Registrant's Current Report on Form 8-K filed on August 1, 2017. | |
12 | Statement re: Computation of Ratios | |
31.1 | Certification of Andreas Fibig pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |
31.2 | Certification of Richard A. O'Leary pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |
32 | Certification of Andreas Fibig and Richard A. O'Leary pursuant to 18 U.S.C. Section 1350 as adopted pursuant to the Sarbanes-Oxley Act of 2002. | |
101.INS | XBRL Instance Document | |
101.SCH | XBRL Taxonomy Extensions Schema | |
101.CAL | XBRL Taxonomy Extension Calculation Linkbase | |
101.DEF | XBRL Taxonomy Extension Definition Linkbase | |
101.LAB | XBRL Taxonomy Extension Label Linkbase | |
101.PRE | XBRL Taxonomy Extension Presentation Linkbase |
Number | Description | |
12 | ||
31.1 | ||
31.2 | ||
32 | ||
101.INS | XBRL Instance Document | |
101.SCH | XBRL Taxonomy Extensions Schema | |
101.CAL | XBRL Taxonomy Extension Calculation Linkbase | |
101.DEF | XBRL Taxonomy Extension Definition Linkbase | |
101.LAB | XBRL Taxonomy Extension Label Linkbase | |
101.PRE | XBRL Taxonomy Extension Presentation Linkbase |
Dated: | November 6, 2017 | By: | /s/ Andreas Fibig | ||
Andreas Fibig | |||||
Chairman of the Board and Chief Executive Officer | |||||
Dated: | November 6, 2017 | By: | /s/ Richard A. O'Leary | ||
Richard A. O'Leary | |||||
Executive Vice President and Chief Financial Officer |
Ratio of Earnings to Fixed Charges | |||||||||||||||||||||||
(Amounts in thousands except Ratio of Earnings to Fixed Charges) | Nine months ended | Fiscal Year | |||||||||||||||||||||
Earnings: | September 30, 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||||||||||||||||
Add: | |||||||||||||||||||||||
Income before taxes | $ | 421,853 | $ | 523,717 | $ | 539,101 | $ | 549,061 | $ | 485,210 | $ | 443,415 | |||||||||||
Fixed charges | 61,544 | 68,838 | 63,158 | 63,098 | 64,194 | 59,009 | |||||||||||||||||
Amortization of capitalized interest | 3,750 | 4,723 | 4,198 | 3,734 | 3,087 | 2,864 | |||||||||||||||||
Less: | |||||||||||||||||||||||
Capitalized interest | (3,099 | ) | (4,035 | ) | (5,893 | ) | (5,572 | ) | (6,629 | ) | (6,762 | ) | |||||||||||
Total Earnings available for fixed charges | $ | 484,048 | $ | 593,243 | $ | 600,564 | $ | 610,321 | $ | 545,862 | $ | 498,526 | |||||||||||
Fixed Charges: | |||||||||||||||||||||||
Interest expense | $ | 49,584 | $ | 52,989 | $ | 46,062 | $ | 46,067 | $ | 46,767 | $ | 41,753 | |||||||||||
Capitalized interest | 3,099 | 4,035 | 5,893 | 5,572 | 6,629 | 6,762 | |||||||||||||||||
Portion of rental expense which represents interest factor1 | 8,861 | 11,814 | 11,203 | 11,459 | 10,798 | 10,494 | |||||||||||||||||
Total Fixed charges | $ | 61,544 | $ | 68,838 | $ | 63,158 | $ | 63,098 | $ | 64,194 | $ | 59,009 | |||||||||||
Ratio of Earnings to Fixed Charges | 7.87 | % | 8.62 | % | 9.51 | % | 9.67 | % | 8.5 | % | 8.45 | % |
1. | I have reviewed this Quarterly Report on Form 10-Q of International Flavors & Fragrances Inc.; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
(a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
(b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
(c) | Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
(d) | Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and |
5. | The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): |
(a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and |
(b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. |
Dated: November 6, 2017 | |||
By: | /s/ Andreas Fibig | ||
Name: | Andreas Fibig | ||
Title: | Chairman of the Board and Chief Executive Officer |
1. | I have reviewed this Quarterly Report on Form 10-Q of International Flavors & Fragrances Inc.; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
(a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
(b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
(c) | Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
(d) | Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and |
5. | The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): |
(a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and |
(b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. |
Dated: November 6, 2017 | |||
By: | /s/ Richard A. O'Leary | ||
Name: | Richard A. O'Leary | ||
Title: | Executive Vice President and Chief Financial Officer |
By: | /s/ Andreas Fibig |
Name: | Andreas Fibig |
Title: | Chairman of the Board and Chief Executive Officer |
Dated: | November 6, 2017 |
By: | /s/ Richard A. O'Leary |
Name: | Richard A. O'Leary |
Title: | Executive Vice President and Chief Financial Officer |
Dated: | November 6, 2017 |
Document and Entity Information - shares |
9 Months Ended | |
---|---|---|
Sep. 30, 2017 |
Oct. 24, 2017 |
|
Document And Entity Information [Abstract] | ||
Entity Registrant Name | INTERNATIONAL FLAVORS & FRAGRANCES INC | |
Entity Central Index Key | 0000051253 | |
Current Fiscal Year End Date | --12-31 | |
Entity Filer Category | Large Accelerated Filer | |
Document Type | 10-Q | |
Document Period End Date | Sep. 30, 2017 | |
Document Fiscal Year Focus | 2017 | |
Document Fiscal Period Focus | Q3 | |
Amendment Flag | false | |
Entity Common Stock, Shares Outstanding | 78,977,158 |
Consolidated Balance Sheet (Parenthetical) - USD ($) $ in Thousands |
Sep. 30, 2017 |
Dec. 31, 2016 |
---|---|---|
Statement of Financial Position [Abstract] | ||
Trade receivables allowances | $ 14,258 | $ 9,995 |
Common stock, par value, in dollars per share | $ 0.125 | $ 0.125 |
Common stock, shares authorized | 500,000,000 | 500,000,000 |
Common stock, shares issued | 115,858,190 | 115,858,190 |
Common stock, shares outstanding | 78,977,158 | 79,213,037 |
Treasury stock, shares at cost | 36,881,032 | 36,645,153 |
Consolidated Statement Of Comprehensive Income - USD ($) shares in Thousands, $ in Thousands |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2017 |
Sep. 30, 2016 |
Sep. 30, 2017 |
Sep. 30, 2016 |
|
Income Statement [Abstract] | ||||
Net sales | $ 872,940 | $ 777,001 | $ 2,544,094 | $ 2,353,790 |
Cost of goods sold | 490,884 | 430,733 | 1,422,783 | 1,281,673 |
Gross profit | 382,056 | 346,268 | 1,121,311 | 1,072,117 |
Research and development expenses | 70,932 | 64,415 | 210,963 | 191,052 |
Selling and administrative expenses | 141,473 | 152,046 | 417,713 | 408,372 |
Amortization of acquisition-related intangibles | 8,766 | 5,468 | 24,327 | 16,659 |
Restructuring and other charges, net | 3,249 | 0 | 14,183 | 0 |
Gain on sales of fixed assets | (31) | (87) | (120) | (2,998) |
Operating profit | 157,667 | 124,426 | 454,245 | 459,032 |
Interest expense | 19,221 | 13,111 | 49,584 | 40,649 |
Other (income) expense, net | (2,880) | (2,075) | (17,192) | (1,954) |
Income before taxes | 141,326 | 113,390 | 421,853 | 420,337 |
Taxes on income | 31,065 | 23,613 | 86,033 | 95,223 |
Net income | 110,261 | 89,777 | 335,820 | 325,114 |
Other comprehensive income, after tax: | ||||
Foreign currency translation adjustments | 19,719 | (6,191) | 29,809 | 3,198 |
(Losses) gains on derivatives qualifying as hedges | (4,014) | 268 | (17,533) | (9,124) |
Pension and postretirement net liability | 3,845 | 2,586 | 11,168 | 7,719 |
Net current period other comprehensive income (loss) | 19,550 | (3,337) | 23,444 | 1,793 |
Total comprehensive income | $ 129,811 | $ 86,440 | $ 359,264 | $ 326,907 |
Net income per share - basic, in dollars per share | $ 1.39 | $ 1.13 | $ 4.24 | $ 4.07 |
Net income per share - diluted, in dollars per share | $ 1.39 | $ 1.12 | $ 4.22 | $ 4.05 |
Average number of shares outstanding - basic | 79,063 | 79,580 | 79,072 | 79,727 |
Average number of shares outstanding - diluted | 79,362 | 79,935 | 79,353 | 80,067 |
Dividends declared per share, in dollars per share | $ 0.69 | $ 0.64 | $ 1.97 | $ 1.76 |
Consolidated Financial Statements |
9 Months Ended |
---|---|
Sep. 30, 2017 | |
Accounting Policies [Abstract] | |
Consolidated Financial Statements | Consolidated Financial Statements: Basis of Presentation These interim statements and related management’s discussion and analysis should be read in conjunction with the Consolidated Financial Statements and the related notes and management’s discussion and analysis of results of operations, liquidity and capital resources included in our 2016 Annual Report on Form 10-K (“2016 Form 10-K”). These interim statements are unaudited. The year-end balance sheet data included in this Form 10-Q was derived from audited financial statements, but does not include all disclosures required by generally accepted accounting principles in the United States of America. We have historically operated and continue to operate on a 52/53 week fiscal year ending on the Friday closest to the last day of the quarter. For ease of presentation, September 30 and December 31 are used consistently throughout this Form 10-Q and these interim financial statements and related notes to represent the period-end dates. For the 2017 and 2016 quarters, the actual closing dates were September 29, and September 30, respectively. The unaudited interim financial statements include all adjustments (consisting only of normal recurring adjustments) and accruals necessary in the judgment of management for a fair statement of the results for the periods presented. When used herein, the terms “IFF,” the “Company,” “we,” “us” and “our” mean International Flavors & Fragrances Inc. and its consolidated subsidiaries. Reclassifications and Revisions Certain prior year amounts have been reclassified and revised to conform with current year presentation. The Consolidated Statement of Comprehensive Income has been revised to properly reflect Gain on sales of fixed assets within Operating profit for the three and nine months ending September 30, 2016. These amounts were previously included in Other (income) expense, net. In addition, approximately $5.4 million of expense was recorded during the first quarter of 2017 for a tax assessment relating to prior periods. The Consolidated Statement of Cash Flows has been revised to properly reclassify $5.4 million from Net cash used in financing activities to Net cash provided by operating activities for the nine months ended September 30, 2016. These adjustments were not material to the current and previously-issued financial statements. Recent Accounting Pronouncements In August 2017, the Financial Accounting Standards Board (“FASB”) issued amendments to the Derivatives and Hedging guidance which eliminates the requirement to separately measure and present hedge ineffectiveness and aligns the presentation of hedge gains and losses with the underlying hedge item. This guidance is effective for fiscal years beginning after December 15, 2018. Early adoption is permitted. The amended presentation and disclosure requirements should be applied prospectively while the amendments to cash flow and net investment hedge relationships should be applied on a modified retrospective basis. The Company is currently evaluating the impact this guidance will have on its Consolidated Financial Statements. In May 2017, the FASB issued amendments to the Compensation - Stock Compensation guidance which clarifies changes to the terms or conditions of a share-based payment award that require an entity to apply modification accounting. This guidance is effective, and should be applied prospectively, for fiscal years beginning after December 15, 2017. Early adoption is permitted. The Company does not expect this guidance to have an impact on its Consolidated Financial Statements as it is not the Company's practice to modify the terms or conditions of a share-based payment award after it has been granted. In March 2017, the FASB issued amendments to the Compensation - Retirement Benefits guidance which requires employers that present a measure of operating income in their statement of income to include only the service cost component of net periodic pension cost and postretirement costs in operating expenses. This guidance is effective, and should be applied retrospectively, for fiscal years beginning after December 15, 2017. Early adoption is permitted as of the beginning of an annual period. The Company expects the impact that this guidance will have on its Consolidated Statement of Comprehensive Income will be an increase in operating expenses of approximately $15 million and $30 million for the fiscal years 2016 and 2017, respectively. There will be no impact to Net income in either period. In January 2017, the FASB issued amendments to the Business Combination guidance which clarifies the definition of a business in order to assist companies when evaluating whether transactions should be accounted for as acquisitions or disposals of assets or businesses. This guidance will be effective prospectively for annual and interim periods beginning after December 15, 2017. The Company is currently evaluating the impact this guidance may have on its consolidated financial statements and on accounting for future acquisitions. In January 2017, the FASB issued an amendment to the Goodwill Impairment guidance which eliminates Step 2 from the goodwill impairment test. This guidance will be effective for fiscal years beginning after December 15, 2019. Early adoption is permitted and the Company has elected to early adopt this guidance and will apply it to its existing annual impairment review policy for fiscal year 2017. The Company does not expect this adoption to have an impact on its consolidated financial statements. In October 2016, the FASB issued authoritative guidance which allows for the immediate recognition of current and deferred income tax impact on intra-entity asset transfers, excluding inventory. This guidance will be effective for fiscal years beginning after December 15, 2017. The Company adopted this guidance in the first quarter of fiscal year 2017 and accordingly, recorded a cumulative-effect adjustment to Retained earnings that reduced Other assets and adjusted Deferred income taxes by a net amount of approximately $33 million. In August 2016, the FASB issued authoritative guidance which requires changes to the classification of certain activities within the statement of cash flows. This guidance will be effective for annual and interim periods beginning after December 15, 2017. Early adoption will be permitted for all entities. The Company does not expect this adoption to have a significant impact on its Consolidated Statement of Cash Flows. In March 2016, the FASB issued authoritative guidance which requires changes to several aspects of the accounting for share-based payment transactions, including the treatment of income tax consequences, classification of awards as either equity or liabilities, and classification of certain items on the statement of cash flows. This guidance was effective for annual and interim periods beginning after December 15, 2016. The Company adopted this standard during the first quarter of 2017. The standard requires that employee taxes paid when an employer withholds shares be presented in the Consolidated Statement of Cash Flows as a financing activity instead of an operating activity. The Company adopted this change retrospectively. The adoption resulted in a $11.5 million and $13.3 million reclassification from Net cash provided by operating activities to Net cash provided by financing activities on the Consolidated Statement of Cash Flows as of September 30, 2017 and 2016, respectively. In addition, the standard requires that excess tax benefits presented in the Consolidated Statement of Cash Flows be classified as an operating activity instead of a financing activity. The Company adopted this change retrospectively. The adoption resulted in a $3.2 million and $4.5 million reclassification from Net cash provided by financing activities to Net cash provided by operating activities on the Consolidated Statement of Cash Flows as of September 30, 2017 and 2016, respectively. The standard also requires all excess tax benefits/deficiencies be recognized as income tax expense/benefit in the Consolidated Statement of Comprehensive Income. This guidance has been applied prospectively. This change resulted in a $3.2 million benefit to income tax expense for the period ended September 30, 2017. The 2016 period included a $1.2 million benefit to equity, which has not been retrospectively adjusted. The full year 2016 benefit to equity was $5.3 million. Additionally, the standard allows the Company to make an entity-wide accounting policy election to either estimate the number of awards that are expected to be forfeited or account for forfeitures as they occur. The Company has elected to continue to account for forfeitures using an estimate of awards expected to be forfeited. In February 2016, the FASB issued authoritative guidance which requires changes to the accounting for leases. The new guidance establishes a new lease accounting model, that requires entities to record assets and liabilities related to leases on the balance sheet for certain types of leases. The guidance will be effective for annual and interim periods beginning after December 15, 2018. Early adoption will be permitted for all entities. The Company expects the adoption of this guidance will result in significant increases to assets and liabilities on its Consolidated Balance Sheet and is still evaluating the impact on its Consolidated Statement of Comprehensive Income. In May 2014, the FASB issued authoritative guidance that provides for a comprehensive model to be used in accounting for revenue arising from contracts with customers. Under this standard, revenue will be recognized to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. This guidance is applicable to all entities and is effective for annual and interim periods beginning after December 15, 2017. Companies have the option to apply the new guidance under a retrospective approach to each prior reporting period presented or a modified retrospective approach with the cumulative effect of initially applying the new guidance recognized at the date of initial application within the Consolidated Balance Sheet. The Company has determined that it will adopt this guidance using the modified retrospective approach. The Company is evaluating the impact of the new standard, including updates to the standard that were issued by the FASB. In particular, the Company has reviewed the nature of its larger customer relationships and is in the process of reviewing the nature of potential regional variations in all aspects of its customer base regardless of size. Based on the work performed to date, the Company expects to conduct further review and analysis of certain areas that may lead to changes in the manner in which the Company recognizes revenue, including the customized nature of the product, consignment arrangements, rebates, upfront costs, shipping terms and documentation other than formal contracts. As a result, the financial statement impact has not yet been determined. The Company continues to evaluate the potential impact of this standard on its consolidated financial statements and related disclosures. Accounts Receivable The Company sells certain accounts receivable on a non-recourse basis to unrelated financial institutions under “factoring” agreements that are sponsored, solely and individually, by certain customers. The Company accounts for these transactions as sales of receivables, removes the receivables sold from its financial statements, and records cash proceeds when received by the Company. The beneficial impact on cash provided by operations from participating in these programs increased approximately $12.1 million for the nine months ended September 30, 2017 compared to an increase of approximately $25.8 million for the nine months ended September 30, 2016. The cost of participating in these programs was immaterial to our results in all periods. Currency Translation Adjustment Reclassification During the first quarter of 2017, the Company recorded income of approximately $12.2 million related to a foreign currency exchange gain from the release of a currency translation adjustment upon the liquidation of a foreign entity in 2017. This amount was recorded to Other (income) expense, net. |
Net Income Per Share |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Net Income Per Share | Net Income Per Share: Net income per share is based on the weighted average number of shares outstanding. A reconciliation of the shares used in the computation of basic and diluted net income per share is as follows:
There were no stock options or stock-settled appreciation rights (“SSARs”) excluded from the computation of diluted net income per share for the three and nine months ended September 30, 2017. An immaterial amount of SSARs were excluded from the 2016 period. The Company has issued shares of purchased restricted common stock and purchased restricted common stock units (collectively “PRSUs”) which contain rights to nonforfeitable dividends while these shares are outstanding and thus are considered participating securities. Such securities are required to be included in the computation of basic and diluted earnings per share pursuant to the two-class method. The Company did not present the two-class method since the difference between basic and diluted net income per share for both unrestricted common shareholders and PRSU shareholders was less than $0.01 per share for each period presented, and the number of PRSUs outstanding as of September 30, 2017 and 2016 was immaterial. Net income allocated to such PRSUs was $0.2 million for both the three months ended September 30, 2017 and 2016 and was $0.7 million and $0.8 million for the nine months ended September 30, 2017 and 2016, respectively. |
Acquisitions |
9 Months Ended |
---|---|
Sep. 30, 2017 | |
Business Combinations [Abstract] | |
Acquisitions | Acquisitions: 2017 Activity PowderPure On April 7, 2017, the Company completed the acquisition of 100% of the outstanding shares of Columbia PhytoTechnology, LLC d/b/a PowderPure ("PowderPure"), a privately-held flavors company with facilities in North America. The acquisition was accounted for under the purchase method. PowderPure was acquired to expand expertise in, and product offerings of, clean label solutions within the Flavors business. The Company paid approximately $55 million including $0.3 million of cash acquired for this acquisition, which was funded from existing resources including use of its revolving credit facility. Additionally, the Company recorded an accrual of approximately $1.4 million representing the current estimate of additional contingent consideration payable to the former owners of PowderPure. (The maximum earnout payable is $10 million upon satisfaction of certain performance metrics). The purchase price exceeded the preliminary fair value of existing net assets by approximately $46.7 million. The excess was allocated principally to identifiable intangible assets including approximately $27.5 million to proprietary technology, approximately $4.5 million to trade name and approximately $0.8 million to customer relationships, and approximately $13.9 million of goodwill (which is deductible for tax purposes). Goodwill is the excess of the purchase price over the fair value of net assets acquired and represents the value the Company expects to achieve from its increased exposure to clean label products within the Company's existing Flavors business. The intangible assets are being amortized over the following estimated useful lives: proprietary technology, 14 years, trade name, 14 years, and customer relationships, 4 years. The purchase price allocation is preliminary pending the finalization of the values of intangible assets, finalization of working capital and the finalization of estimated useful lives. The purchase price allocation is expected to be completed by the fourth quarter of 2017. No pro forma financial information for 2017 and 2016 is presented as the acquisition was not material to the consolidated financial statements. Fragrance Resources On January 17, 2017, the Company completed the acquisition of 100% of the outstanding shares of Fragrance Resources, a privately-held fragrance company with facilities in Germany, North America, France, and China. The acquisition was accounted for under the purchase method. Fragrance Resources was acquired to strengthen the North American and German Fragrances business. The Company paid approximately Euro 142.0 million (approximately $150.5 million) including approximately Euro 13.7 million (approximately $14.5 million) of cash acquired for this acquisition, which was funded from existing resources including use of its revolving credit facility. The purchase price exceeded the preliminary fair value of existing net assets by approximately $122.1 million. The excess was allocated principally to identifiable intangible assets including approximately $59.6 million related to customer relationships, approximately $6.1 million related to proprietary technology and trade name, and approximately $79.4 million of goodwill (which is not deductible for tax purposes) and approximately $23.0 million of net deferred tax liability. Goodwill is the excess of the purchase price over the fair value of net assets acquired and represents synergies from the addition of Fragrance Resources to the Company's existing Fragrances business. The intangible assets are being amortized over the following estimated useful lives: trade name, 2 years, proprietary technology, 5 years and customer relationships, 12 - 16 years. The purchase price allocation is preliminary pending the finalization of the values of intangible assets, principally customer relationships, finalization of working capital calculations and the finalization of estimated useful lives. The purchase price allocation is expected to be completed by the fourth quarter of 2017. No pro forma financial information for 2017 and 2016 is presented as the acquisition was not material to the consolidated financial statements. 2016 Activity David Michael On October 7, 2016, the Company completed the acquisition of 100% of the outstanding shares of David Michael & Company, Inc. ("David Michael"). The acquisition was accounted for under the purchase method. David Michael was acquired to strengthen the North American flavors business. The Company paid approximately $242.6 million (including $5.1 million of cash acquired) for this acquisition, which was funded from existing resources. The preliminary purchase price allocation was updated during the first quarter of 2017, resulting in a reduction in allocation of value to customer relationships. The related reduction in amortization expense was not material to the Consolidated Statement of Comprehensive Income. The purchase price allocation was finalized during the second quarter of 2017. Additionally, during the second quarter of 2017, the Company finalized the working capital adjustment and paid an additional $0.6 million. The purchase price exceeded the fair value of existing net assets by approximately $168.7 million. The excess was allocated principally to identifiable intangible assets including approximately $50.0 million related to customer relationships, approximately $8.4 million related to proprietary technology and trade name, and approximately $110.2 million of goodwill (which is deductible for tax purposes). Goodwill is the excess of the purchase price over the fair value of net assets acquired and represents synergies from the addition of David Michael to the Company's existing Flavors business. The intangible assets are being amortized over the following estimated useful lives: trade name, 2 years, proprietary technology, 5 years and customer relationships, 18 - 20 years. No pro forma financial information for 2016 is presented as the impact of the acquisition was immaterial to the Consolidated Statement of Comprehensive Income. |
Goodwill and Other Intangible Assets, Net Goodwill and Other Intangible Assets, Net (Notes) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goodwill and Intangible Assets Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goodwill and Other Intangible Assets, Net | Goodwill and Other Intangible Assets, Net: Goodwill Movements in goodwill during 2017 were as follows:
Other above principally represents the increase to Goodwill associated with the update of certain customer relationship assumptions in the final purchase price allocation of David Michael, as disclosed in Note 3. Other Intangible Assets Other intangible assets, net consist of the following amounts:
Amortization Amortization expense was $8.8 million and $5.5 million for the three months ended September 30, 2017 and 2016, respectively and $24.3 million and $16.7 million for the nine months ended September 30, 2017 and 2016, respectively. Annual amortization is expected to be $35.6 million for the full year 2017, $34.9 million for the year 2018, $33.3 million for the year 2019, $32.6 million for the year 2020, $27.9 million for the year 2021 and $25.5 million for the year 2022. |
Restructuring and Other Charges, Net |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Restructuring and Related Activities [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Restructuring and Other Charges, Net | Restructuring and Other Charges, Net: 2017 Productivity Program On February 15, 2017, the Company announced that it was adopting a multi-year productivity program designed to improve overall financial performance, provide flexibility to invest in growth opportunities and drive long-term value creation. In connection with this program, the Company expects to optimize its global footprint and simplify its organizational structures globally. In connection with this initiative, the Company expects to incur cumulative, pre-tax cash charges of between $30-$35 million, consisting primarily of $21-$22 million in personnel-related costs and an estimated $9-$13 million in facility-related costs, such as lease termination, and integration-related costs. In addition, the Company may incur up to $5 million of accelerated depreciation. The Company recorded $16.5 million of charges related to personnel-related costs and lease termination costs through the third quarter of 2017, of which $3.2 million was recorded during the third quarter of 2017, with the remainder of the personnel-related and other costs expected to be recognized by the end of 2018. The Company made payments of $10.0 million related to severance in 2017. The overall charges were split approximately evenly between Flavors and Fragrances. This initiative is expected to result in the reduction of approximately 370 members of the Company’s global workforce, including acquired entities, in various parts of the organization. 2015 Severance Charges During 2015, the Company established a series of initiatives intended to streamline its management structure, simplify decision-making and accountability, better leverage and align its capabilities across the organization and improve efficiency of its global manufacturing and operations network. As a result, the Company recorded charges for severance and related costs pertaining to approximately 150 positions that were affected. During 2017, the Company made payments of $0.2 million related to severance and recorded a credit of $2.3 million related to the reversal of severance accruals that were determined to be no longer required. No further actions are expected in 2017 related to these 2015 initiatives. Changes in employee-related restructuring liabilities during the nine months ended September 30, 2017, were as follows:
|
Borrowings |
9 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2017 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Disclosure [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Borrowings | Borrowings: Debt consists of the following:
(1) Amount is net of unamortized discount and debt issuance costs. Senior Notes - 2017 On May 18, 2017, the Company issued $500.0 million face amount of 4.375% Senior Notes ("Senior Notes - 2017") due 2047 at a discount of $1.8 million. The Company received proceeds related to the issuance of these Senior Notes - 2017 of $493.9 million which was net of the $1.8 million discount and $4.4 million in underwriting fees (recorded as deferred financing costs). In addition, the Company incurred $0.9 million in legal and professional costs associated with the issuance and such costs were recorded as deferred financing costs. In connection with the debt issuance, the Company entered into pre-issuance hedging transactions that were settled upon issuance of the debt and resulted in a loss of approximately $5.3 million. The discount, deferred financing costs and pre-issuance hedge loss are being amortized as interest expense over the 30 year term of the debt. The Senior Notes - 2017 bear interest at a rate of 4.375% per annum, with interest payable semi-annually on June 1 and December 1 of each year, commencing on December 1, 2017. The Senior Notes - 2017 will mature on June 1, 2047. Upon 30 days’ notice to holders of the Senior Notes - 2017, the Company may redeem the Senior Notes - 2017 for cash in whole, at any time, or in part, from time to time, prior to maturity, at redemption prices that include accrued and unpaid interest and a make-whole premium, as specified in the Indenture governing the Senior Notes - 2017. However, no make-whole premium will be paid for redemptions of the Senior Notes - 2017 on or after December 1, 2046. The Indenture provides for customary events of default and contains certain negative covenants that limit the ability of the Company and its subsidiaries to grant liens on assets, or to enter into sale-leaseback transactions. In addition, subject to certain limitations, in the event of the occurrence of both (1) a change of control of the Company and (2) a downgrade of the Senior Notes - 2017 below investment grade rating by both Moody’s Investors Services, Inc. and Standard & Poor’s Ratings Services within a specified time period, the Company will be required to make an offer to repurchase the Senior Notes - 2017 at a price equal to 101% of the principal amount of the Senior Notes - 2017, plus accrued and unpaid interest to the date of repurchase. Senior Notes - 2007 During the third quarter of 2017, the Company made a payment of $250 million on the Senior Notes - 2007. Commercial Paper Commercial paper issued by the Company generally has terms of 90 days or less. As of September 30, 2017, there was $40.0 million of commercial paper outstanding, which had a weighted average effective interest rate of 1.19%. As of September 30, 2017, commercial paper maturities did not extend for more than 30 days. The revolving credit facility is used as a backstop for the Company's commercial paper program. No commercial paper was issued during the nine months ended September 30, 2016. |
Income Taxes |
9 Months Ended |
---|---|
Sep. 30, 2017 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes: Uncertain Tax Positions At September 30, 2017, the Company had $18.9 million of unrecognized tax benefits recorded in Other liabilities and $6.9 million in Other current liabilities. If these unrecognized tax benefits were recognized, the effective tax rate would be affected. At September 30, 2017, the Company had accrued interest and penalties of $1.7 million classified in Other liabilities and $0.7 million in Other current liabilities. As of September 30, 2017, the Company’s aggregate provisions for uncertain tax positions, including interest and penalties, was $28.2 million associated with various tax positions asserted in various jurisdictions, none of which is individually material. The Company regularly repatriates a portion of current year earnings from select non–U.S. subsidiaries. No provision is made for additional taxes on undistributed earnings of subsidiary companies that are intended and planned to be indefinitely invested in such subsidiaries. We intend to, and have plans to, reinvest these earnings indefinitely in our foreign subsidiaries to fund local operations and/or capital projects. The Company has ongoing income tax audits and legal proceedings which are at various stages of administrative or judicial review. In addition, the Company has open tax years with various taxing jurisdictions that range primarily from 2007 to 2016. Based on currently available information, we do not believe the ultimate outcome of any of these tax audits and other tax positions related to open tax years, when finalized, will have a material impact on our financial position. The Company also has other ongoing tax audits and legal proceedings that relate to indirect taxes, such as value-added taxes, sales and use taxes and property taxes, which are discussed in Note 13. Effective Tax Rate The effective tax rate for the three months ended September 30, 2017 was 22.0% compared with 20.8% for the three months ended September 30, 2016. The quarter-over-quarter increase was largely due to higher repatriation costs partially offset by the impact of the global supply chain hub and mix of earnings as compared to the prior year. The effective tax rate for the nine months ended September 30, 2017 was 20.4% compared with 22.7% for the nine months ended September 30, 2016. The period-over-period decrease was primarily due to certain non-taxable gains on foreign currency and the impact of adopting the new accounting guidance on the tax effect of stock compensation vesting, a more favorable mix of earnings and the impact of the global supply chain hub, offset by unfavorable repatriation costs as compared to the prior year. |
Stock Compensation Plans |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock Compensation Plans | Stock Compensation Plans The Company has various plans under which its officers, senior management, other key employees and directors may be granted equity-based awards. Equity awards outstanding under the plans include PRSUs, restricted stock units (RSUs), stock options, SSARs and Long-Term Incentive Plan awards; liability-based awards outstanding under the plans are cash-settled RSUs. Stock-based compensation expense and related tax benefits were as follows:
|
Segment Information |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Information | Segment Information: The Company is organized into two operating segments: Flavors and Fragrances. These segments align with the internal structure of the Company used to manage these businesses. Performance of these operating segments is evaluated based on segment profit which is defined as operating profit before Restructuring and other charges, net, Global expenses (as discussed below) and certain non-recurring items, Interest expense, Other income (expense), net and Taxes on income. The Global expenses caption below represent corporate and headquarters-related expenses which include legal, finance, human resources, certain incentive compensation expenses and other R&D and administrative expenses that are not allocated to individual operating segments. Reportable segment information is as follows:
Net sales are attributed to individual regions based upon the destination of product delivery. Net sales related to the U.S. for the three months ended September 30, 2017 and 2016 were $251 million and $190 million, respectively and for the nine months ended September 30, 2017 and 2016 were $731 million and $555 million, respectively. Net sales attributed to all foreign countries in total for the three months ended September 30, 2017 and 2016 were $622 million and $587 million, respectively and for the nine months ended September 30, 2017 and 2016 were $1,813 million and $1,799 million, respectively. No country other than the U.S. had net sales in any period presented greater than 10% of total consolidated net sales. |
Employee Benefits |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Retirement Benefits [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Employee Benefits | Employee Benefits: Pension and other defined contribution retirement plan expenses included the following components:
The Company expects to contribute a total of approximately $3 - $10 million to its U.S. pension plans during 2017. During the nine months ended September 30, 2017, no contributions were made to the qualified U.S. pension plans, $33.6 million of contributions were made to the non-U.S. pension plans and $3.3 million of benefit payments were made with respect to the Company's non-qualified U.S. pension plan. As of January 1, 2017, the Company changed its approach for calculating the discount rate which is applied to the Consolidated Balance Sheet and Consolidated Statement of Comprehensive Income from a single weighted-average discount rate approach to a multiple discount rate approach. The impact of this change for the full year 2017 is estimated to be a reduction of approximately $8 million in pension expense. Expense recognized for postretirement benefits other than pensions included the following components:
The Company expects to contribute approximately $5 million to its postretirement benefits other than pension plans during 2017. In the nine months ended September 30, 2017, $3.1 million of contributions were made. |
Financial Instruments |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investments, All Other Investments [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Instruments | Financial Instruments: Fair Value Accounting guidance on fair value measurements specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our market assumptions. These two types of inputs create the following fair value hierarchy:
This hierarchy requires us to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value. We determine the fair value of structured liabilities (where performance is linked to structured interest rates, inflation or currency risks) using the LIBOR swap curve and forward interest and exchange rates at period end. Such instruments are classified as Level 2 based on the observability of significant inputs to the model. We do not have any instruments classified as Level 1 or Level 3, other than those included in pension asset trusts as discussed in Note 14 of our 2016 Form 10-K. These valuations take into consideration our credit risk and our counterparties’ credit risk. The estimated change in the fair value of these instruments due to such changes in our own credit risk (or instrument-specific credit risk) was immaterial as of September 30, 2017. The amounts recorded in the balance sheet (carrying amount) and the estimated fair values of financial instruments at September 30, 2017 and December 31, 2016 consisted of the following:
Derivatives The Company periodically enters into foreign currency forward contracts with the objective of reducing exposure to cash flow volatility associated with our intercompany loans, foreign currency receivables and payables, and anticipated purchases of certain raw materials used in operations. These contracts generally involve the exchange of one currency for a second currency at a future date, have maturities not exceeding twelve months and are with counterparties which are major international financial institutions. During the nine months ended September 30, 2017 and the year ended December 31, 2016, the Company entered into several forward currency contracts which qualified as net investment hedges, in order to mitigate a portion of our net European investments from foreign currency risk. The effective portions of net investment hedges are recorded in Other comprehensive income (“OCI”) as a component of Foreign currency translation adjustments in the accompanying Consolidated Statement of Comprehensive Income. Realized gains (losses) are deferred in accumulated other comprehensive income ("AOCI") where they will remain until the net investments in our European subsidiaries are divested. The outstanding forward currency contracts have remaining maturities of approximately one year. Fourteen of these forward currency contracts matured during the nine months ended September 30, 2017. Subsequent to the issuance of the Euro Senior Notes - 2016 during the first quarter of 2016, the Company designated the debt as a hedge of a portion of its net European investments. Accordingly, the change in the value of the debt that is attributable to foreign exchange movements is recorded in OCI as a component of Foreign currency translation adjustments in the accompanying Consolidated Statement of Comprehensive Income. During the nine months ended September 30, 2017 and the year ended December 31, 2016, the Company entered into several forward currency contracts which qualified as cash flow hedges. The objective of these hedges is to protect against the currency risk associated with forecasted U.S. dollar (USD) denominated raw material purchases made by Euro (EUR) functional currency entities which result from changes in the EUR/USD exchange rate. The effective portions of cash flow hedges are recorded in OCI as a component of gains/(losses) on derivatives qualifying as hedges in the accompanying Consolidated Statement of Comprehensive Income. Realized gains/(losses) in AOCI related to cash flow hedges of raw material purchases are recognized as a component of Cost of goods sold in the accompanying Consolidated Statement of Comprehensive Income in the same period as the related costs are recognized. The Company has entered into interest rate swap agreements that effectively converted the fixed rate on a portion of our long-term borrowings to a variable short-term rate based on the LIBOR plus an interest markup. These swaps are designated as fair value hedges. Amounts recognized in Interest expense were immaterial for the three and nine months ended September 30, 2017. During the first quarter of 2016, the Company entered into and terminated two Euro interest rate swap agreements to hedge the anticipated issuance of fixed-rate debt. These swaps were designated as cash flow hedges. The effective portions of cash flow hedges are recorded in OCI as a component of Losses on derivatives qualifying as hedges in the accompanying Consolidated Statement of Comprehensive Income. The Company incurred a loss of Euro 2.9 million ($3.2 million) due to the termination of these swaps. The loss is being amortized as interest expense over the life of the Euro Senior Notes - 2016. During the fourth quarter of 2016 and the first quarter of 2017, the Company entered into interest rate swap agreements to hedge the anticipated issuance of fixed-rate debt, which are designated as cash flow hedges. The various hedge instruments were settled upon issuance of the debt on May 18, 2017 and resulted in a loss of approximately $5.3 million. As discussed in Note 6, the loss is being amortized as interest expense over the life of the Senior Notes - 2017. The effective portions of cash flow hedges are recorded in OCI as a component of Losses/gains on derivatives qualifying as hedges in the accompanying Consolidated Statement of Comprehensive Income. The following table shows the notional amount of the Company’s derivative instruments outstanding as of September 30, 2017 and December 31, 2016:
The following tables show the Company’s derivative instruments measured at fair value (Level 2 of the fair value hierarchy), as reflected in the Consolidated Balance Sheets as of September 30, 2017 and December 31, 2016:
The following table shows the effect of the Company’s derivative instruments which were not designated as hedging instruments in the Consolidated Statement of Comprehensive Income for the three and nine months ended September 30, 2017 and 2016 (in thousands):
Most of these net gains (losses) offset any recognized gains (losses) arising from the revaluation of the related intercompany loans during the same respective periods. The following table shows the effect of the Company’s derivative instruments designated as cash flow and net investment hedging instruments, net of tax, in the Consolidated Statements of Comprehensive Income for the three and nine months ended September 30, 2017 and 2016 (in thousands):
(1) Interest rate swaps were entered into as pre-issuance hedges. No ineffectiveness was experienced in the above noted cash flow or net investment hedges during the three and nine months ended September 30, 2017 and 2016. The Company expects that approximately $5.4 million (net of tax) of derivative loss included in AOCI at September 30, 2017, based on current market rates, will be reclassified into earnings within the next 12 months. The majority of this amount will vary due to fluctuations in foreign currency exchange rates. |
Accumulated Other Comprehensive Income (Loss) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accumulated Other Comprehensive Income (Loss) | Accumulated Other Comprehensive Income (Loss): The following tables present changes in the accumulated balances for each component of other comprehensive income, including current period other comprehensive income and reclassifications out of accumulated other comprehensive income:
* Represents a foreign currency exchange gain from the release of a currency translation adjustment upon the liquidation of a foreign entity in 2017 as disclosed in Note 1.
The following table provides details about reclassifications out of accumulated other comprehensive income to the Consolidated Statement of Comprehensive Income:
|
Commitments and Contingencies |
9 Months Ended |
---|---|
Sep. 30, 2017 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies: Guarantees and Letters of Credit The Company has various bank guarantees and letters of credit which are available for use to support its ongoing business operations and to satisfy governmental requirements associated with pending litigation in various jurisdictions. At September 30, 2017, we had total bank guarantees and standby letters of credit of approximately $38.1 million with various financial institutions. Included in the above aggregate amount is a total of $16.3 million in bank guarantees which the Company has posted for certain assessments in Brazil for other diverse income tax and indirect tax disputes related to fiscal years 1998-2011. There were no material amounts utilized under the standby letters of credit as of September 30, 2017. In order to challenge the assessments in these cases in Brazil, the Company has been required to, and has separately pledged assets, principally property, plant and equipment, to cover assessments in the amount of approximately $15.6 million as of September 30, 2017. Lines of Credit The Company has various lines of credit which are available to support its ongoing business operations. At September 30, 2017, we had available lines of credit (in addition to the $950 million of capacity under the Credit Facility discussed in Note 9 of our 2016 Form 10-K) of approximately $75.6 million with various financial institutions. There were no significant amounts drawn down pursuant to these lines of credit as of September 30, 2017. Litigation The Company assesses contingencies related to litigation and/or other matters to determine the degree of probability and range of possible loss. A loss contingency is accrued in the Company’s consolidated financial statements if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Because litigation is inherently unpredictable and unfavorable resolutions could occur, assessing contingencies is highly sensitive and requires judgments about future events. On at least a quarterly basis, the Company reviews contingencies related to litigation to determine the adequacy of accruals. The amount of ultimate loss may differ from these estimates and further events may require the Company to increase or decrease the amounts it has accrued on any matter. Periodically, we assess our insurance coverage for all known claims, where applicable, taking into account aggregate coverage by occurrence, limits of coverage, self-insured retentions and deductibles, historical claims experience and claims experience with our insurance carriers. The liabilities are recorded at management’s best estimate of the probable outcome of the lawsuits and claims, taking into consideration the facts and circumstances of the individual matters as well as past experience on similar matters. At each balance sheet date, the key issues that management assesses are whether it is probable that a loss as to asserted or unasserted claims has been incurred and if so, whether the amount of loss can be reasonably estimated. We record the expected liability with respect to claims in Other liabilities and expected recoveries from our insurance carriers in Other assets. We recognize a receivable when we believe that realization of the insurance receivable is probable under the terms of the insurance policies and our payment experience to date. Environmental Over the past 20 years, various federal and state authorities and private parties have claimed that we are a Potentially Responsible Party (“PRP”) as a generator of waste materials for alleged pollution at a number of waste sites operated by third parties located principally in New Jersey and have sought to recover costs incurred and to be incurred to clean up the sites. We have been identified as a PRP at eight facilities operated by third parties at which investigation and/or remediation activities may be ongoing. We analyze our potential liability on at least a quarterly basis. We accrue for environmental liabilities when they are probable and estimable. We estimate our share of the total future cost for these sites to be less than $5 million. While joint and several liability is authorized under federal and state environmental laws, we believe the amounts we have paid and anticipate paying in the future for clean-up costs and damages at all sites are not material and will not have a material adverse effect on our financial condition, results of operations or liquidity. This assessment is based upon, among other things, the involvement of other PRPs at most of the sites, the status of the proceedings, including various settlement agreements and consent decrees, and the extended time period over which payments will likely be made. There can be no assurance, however, that future events will not require us to materially increase the amounts we anticipate paying for clean-up costs and damages at these sites, and that such increased amounts will not have a material adverse effect on our financial condition, results of operations or cash flows. China Facilities Guangzhou Flavors plant During 2015, the Company was notified by Chinese authorities of compliance issues pertaining to the emission of odors from several of its plants in China. As a result, the Company's Guangzhou Flavors plant in China was temporarily idled in 2015. The Company has made additional capital improvements in odor-abatement equipment at these plants to address these issues and is in the process of building a second Flavors plant in China, which is expected to begin operating in the first quarter of 2019. During the fourth quarter of 2016, the Company was notified that certain governmental authorities have begun to evaluate a change in the zoning of the Guangzhou Flavors plant. The zoning, if changed, would prevent the Company from continuing to manufacture product at the existing plant. The ultimate outcome of any change that the governmental authorities may propose, the timing of such a change and the nature of any compensation arrangements that might be provided to the Company are uncertain. The net book value of the existing plant was approximately $68 million as of September 30, 2017. Zhejiang Ingredients plant In the first quarter of 2016, the Company received a request from the Chinese government to relocate its Fragrance Ingredients plant in Zhejiang, China. Since then, the Company has been in discussions with the government regarding the timing of the requested relocation and the amount and nature of government compensation to be provided to the Company. The Company expects to conclude discussions with the government in the fourth quarter of 2017. The net book value of the current plant was approximately $25 million as of September 30, 2017. Based on the current expectations regarding the compensation package, the Company estimates that between $0-12 million of the remaining net book value may be subject to accelerated depreciation beginning in the fourth quarter of 2017. The Company expects to relocate approximately half of the facility by the end of 2018 and the remainder of the facility by the end of 2019. Total China Operations The total carrying value of our six existing plants in China (two of which are currently under construction) was approximately $145 million as of September 30, 2017. If the Company is required to close a plant, or operate one at significantly reduced production levels on a permanent basis, the Company may be required to record charges that could have a material impact on its consolidated financial results of operations, financial position and cash flows in future periods. Other Contingencies The Company has contingencies involving third parties (such as labor, contract, technology or product-related claims or litigation) as well as government-related items in various jurisdictions in which we operate pertaining to such items as value-added taxes, other indirect taxes, customs and duties and sales and use taxes. It is possible that cash flows or results of operations, in any period, could be materially affected by the unfavorable resolution of one or more of these contingencies. The most significant government-related contingencies exist in Brazil. With regard to the Brazilian matters, we believe we have valid defenses for the underlying positions under dispute; however, in order to pursue these defenses, we are required to, and have provided, bank guarantees and pledged assets in the aggregate amount of $31.9 million. The Brazilian matters take an extended period of time to proceed through the judicial process and there are a limited number of rulings to date. As previously disclosed, in March 2012, ZoomEssence, Inc. filed a complaint against the Company in the U.S. District Court for the District of New Jersey alleging trade secret misappropriation, breach of contract and unjust enrichment in connection with certain spray dry technology disclosed to the Company. ZoomEssence sought an injunction and monetary damages. In November 2014, the Company filed a counterclaim against ZoomEssence alleging trade secret misappropriation, breach of contract, breach of the implied covenant of good faith and fair dealing, unjust enrichment, misappropriation of confidential and proprietary information, common law unfair competition, tortious interference with contractual relations, and conversion. During the second quarter of 2017, the Company and ZoomEssence mutually agreed to settle all claims and counterclaims. The parties agreed to dismiss their claims against one another, with prejudice and without any admission of liability or wrongful conduct, to avoid any further expense and disruption from the litigation. The complaint was dismissed, with prejudice, on July 5, 2017. Under the settlement agreement, the Company made a one-time payment to ZoomEssence of $56 million during the second quarter of 2017 and the parties exchanged full mutual releases. Accordingly, the Company recorded an additional charge of $1 million during the second quarter of 2017. The Company periodically incurs product liability claims based on product that is sold to customers that may be defective or otherwise not in accordance with the customer’s requirements. As previously disclosed, in the first quarter of 2017, the Company was made aware of a claim for product that was subject to a product recall. As of September 30, 2017, the Company had recorded a total charge of approximately $5.3 million with respect to this claim. In addition to the charge of $1.8 million recorded in the first quarter of 2017, an additional $3.5 million was recorded during the second quarter of 2017. The second quarter charge reflects additional information on specific volumes of affected products, which information became available in the second quarter of 2017. This amount principally represents an accrual for the claim based on management's best estimate of volumes of customer products subject to the recall. Additionally, appropriate reserves have been established for all remaining inventory at the Company's manufacturing site. While it is probable that the Company will incur additional losses related to this claim, the amount of the ultimate claim that will be paid is not currently estimable as the following information is not yet available: details as to the amount of product that will ultimately be returned and the customer’s direct manufacturing and other production costs; costs related to the customer’s recall efforts; costs to dispose of defective product; and other claims that the customer may make. While it is not currently possible to estimate the amount of losses, such losses when recorded will affect income from operations in future individual quarters. The Company does not believe that the ultimate settlement of the claim will have a material impact on its financial condition. Separately, the Company expects to pursue reimbursement of all or a portion of costs, once incurred, from its insurance company and/or the supplier; however, the nature, timing and amount of any such reimbursement cannot be determined at this time. The Company determines estimates of reasonably possible losses or ranges of reasonably possible losses in excess of related accrued liabilities, if any, when it has determined that either a loss is reasonably possible or a loss in excess of accrued amounts is reasonably possible and the amount of losses or range of losses is determinable. For all third party contingencies (including labor, contract, technology, tax, product-related claims and business litigation), the Company currently estimates that the aggregate range of reasonably possible estimable losses in excess of any accrued liabilities is $0 to approximately $23 million. The estimates included in this amount are based on the Company’s analysis of currently available information and, as new information is obtained, these estimates may change. Due to the inherent subjectivity of the assessments and the unpredictability of outcomes of legal proceedings, any amounts accrued or included in this aggregate amount may not represent the ultimate loss to the Company from the matters in question. Thus, the Company’s exposure and ultimate losses may be higher or lower, and possibly significantly so, than the amounts accrued or the range disclosed above. We are also a party to other litigation arising in the ordinary course of our business. We do not expect the outcome of these cases, singly or in the aggregate, to have a material effect on our consolidated financial condition. |
Consolidated Financial Statements (Policies) |
9 Months Ended |
---|---|
Sep. 30, 2017 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation These interim statements and related management’s discussion and analysis should be read in conjunction with the Consolidated Financial Statements and the related notes and management’s discussion and analysis of results of operations, liquidity and capital resources included in our 2016 Annual Report on Form 10-K (“2016 Form 10-K”). These interim statements are unaudited. The year-end balance sheet data included in this Form 10-Q was derived from audited financial statements, but does not include all disclosures required by generally accepted accounting principles in the United States of America. We have historically operated and continue to operate on a 52/53 week fiscal year ending on the Friday closest to the last day of the quarter. For ease of presentation, September 30 and December 31 are used consistently throughout this Form 10-Q and these interim financial statements and related notes to represent the period-end dates. For the 2017 and 2016 quarters, the actual closing dates were September 29, and September 30, respectively. The unaudited interim financial statements include all adjustments (consisting only of normal recurring adjustments) and accruals necessary in the judgment of management for a fair statement of the results for the periods presented. When used herein, the terms “IFF,” the “Company,” “we,” “us” and “our” mean International Flavors & Fragrances Inc. and its consolidated subsidiaries. |
Reclassifications and Revisions | Reclassifications and Revisions Certain prior year amounts have been reclassified and revised to conform with current year presentation. The Consolidated Statement of Comprehensive Income has been revised to properly reflect Gain on sales of fixed assets within Operating profit for the three and nine months ending September 30, 2016. These amounts were previously included in Other (income) expense, net. In addition, approximately $5.4 million of expense was recorded during the first quarter of 2017 for a tax assessment relating to prior periods. The Consolidated Statement of Cash Flows has been revised to properly reclassify $5.4 million from Net cash used in financing activities to Net cash provided by operating activities for the nine months ended September 30, 2016. These adjustments were not material to the current and previously-issued financial statements. |
Recent Accounting Pronouncements | Recent Accounting Pronouncements In August 2017, the Financial Accounting Standards Board (“FASB”) issued amendments to the Derivatives and Hedging guidance which eliminates the requirement to separately measure and present hedge ineffectiveness and aligns the presentation of hedge gains and losses with the underlying hedge item. This guidance is effective for fiscal years beginning after December 15, 2018. Early adoption is permitted. The amended presentation and disclosure requirements should be applied prospectively while the amendments to cash flow and net investment hedge relationships should be applied on a modified retrospective basis. The Company is currently evaluating the impact this guidance will have on its Consolidated Financial Statements. In May 2017, the FASB issued amendments to the Compensation - Stock Compensation guidance which clarifies changes to the terms or conditions of a share-based payment award that require an entity to apply modification accounting. This guidance is effective, and should be applied prospectively, for fiscal years beginning after December 15, 2017. Early adoption is permitted. The Company does not expect this guidance to have an impact on its Consolidated Financial Statements as it is not the Company's practice to modify the terms or conditions of a share-based payment award after it has been granted. In March 2017, the FASB issued amendments to the Compensation - Retirement Benefits guidance which requires employers that present a measure of operating income in their statement of income to include only the service cost component of net periodic pension cost and postretirement costs in operating expenses. This guidance is effective, and should be applied retrospectively, for fiscal years beginning after December 15, 2017. Early adoption is permitted as of the beginning of an annual period. The Company expects the impact that this guidance will have on its Consolidated Statement of Comprehensive Income will be an increase in operating expenses of approximately $15 million and $30 million for the fiscal years 2016 and 2017, respectively. There will be no impact to Net income in either period. In January 2017, the FASB issued amendments to the Business Combination guidance which clarifies the definition of a business in order to assist companies when evaluating whether transactions should be accounted for as acquisitions or disposals of assets or businesses. This guidance will be effective prospectively for annual and interim periods beginning after December 15, 2017. The Company is currently evaluating the impact this guidance may have on its consolidated financial statements and on accounting for future acquisitions. In January 2017, the FASB issued an amendment to the Goodwill Impairment guidance which eliminates Step 2 from the goodwill impairment test. This guidance will be effective for fiscal years beginning after December 15, 2019. Early adoption is permitted and the Company has elected to early adopt this guidance and will apply it to its existing annual impairment review policy for fiscal year 2017. The Company does not expect this adoption to have an impact on its consolidated financial statements. In October 2016, the FASB issued authoritative guidance which allows for the immediate recognition of current and deferred income tax impact on intra-entity asset transfers, excluding inventory. This guidance will be effective for fiscal years beginning after December 15, 2017. The Company adopted this guidance in the first quarter of fiscal year 2017 and accordingly, recorded a cumulative-effect adjustment to Retained earnings that reduced Other assets and adjusted Deferred income taxes by a net amount of approximately $33 million. In August 2016, the FASB issued authoritative guidance which requires changes to the classification of certain activities within the statement of cash flows. This guidance will be effective for annual and interim periods beginning after December 15, 2017. Early adoption will be permitted for all entities. The Company does not expect this adoption to have a significant impact on its Consolidated Statement of Cash Flows. In March 2016, the FASB issued authoritative guidance which requires changes to several aspects of the accounting for share-based payment transactions, including the treatment of income tax consequences, classification of awards as either equity or liabilities, and classification of certain items on the statement of cash flows. This guidance was effective for annual and interim periods beginning after December 15, 2016. The Company adopted this standard during the first quarter of 2017. The standard requires that employee taxes paid when an employer withholds shares be presented in the Consolidated Statement of Cash Flows as a financing activity instead of an operating activity. The Company adopted this change retrospectively. The adoption resulted in a $11.5 million and $13.3 million reclassification from Net cash provided by operating activities to Net cash provided by financing activities on the Consolidated Statement of Cash Flows as of September 30, 2017 and 2016, respectively. In addition, the standard requires that excess tax benefits presented in the Consolidated Statement of Cash Flows be classified as an operating activity instead of a financing activity. The Company adopted this change retrospectively. The adoption resulted in a $3.2 million and $4.5 million reclassification from Net cash provided by financing activities to Net cash provided by operating activities on the Consolidated Statement of Cash Flows as of September 30, 2017 and 2016, respectively. The standard also requires all excess tax benefits/deficiencies be recognized as income tax expense/benefit in the Consolidated Statement of Comprehensive Income. This guidance has been applied prospectively. This change resulted in a $3.2 million benefit to income tax expense for the period ended September 30, 2017. The 2016 period included a $1.2 million benefit to equity, which has not been retrospectively adjusted. The full year 2016 benefit to equity was $5.3 million. Additionally, the standard allows the Company to make an entity-wide accounting policy election to either estimate the number of awards that are expected to be forfeited or account for forfeitures as they occur. The Company has elected to continue to account for forfeitures using an estimate of awards expected to be forfeited. In February 2016, the FASB issued authoritative guidance which requires changes to the accounting for leases. The new guidance establishes a new lease accounting model, that requires entities to record assets and liabilities related to leases on the balance sheet for certain types of leases. The guidance will be effective for annual and interim periods beginning after December 15, 2018. Early adoption will be permitted for all entities. The Company expects the adoption of this guidance will result in significant increases to assets and liabilities on its Consolidated Balance Sheet and is still evaluating the impact on its Consolidated Statement of Comprehensive Income. In May 2014, the FASB issued authoritative guidance that provides for a comprehensive model to be used in accounting for revenue arising from contracts with customers. Under this standard, revenue will be recognized to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. This guidance is applicable to all entities and is effective for annual and interim periods beginning after December 15, 2017. Companies have the option to apply the new guidance under a retrospective approach to each prior reporting period presented or a modified retrospective approach with the cumulative effect of initially applying the new guidance recognized at the date of initial application within the Consolidated Balance Sheet. The Company has determined that it will adopt this guidance using the modified retrospective approach. The Company is evaluating the impact of the new standard, including updates to the standard that were issued by the FASB. In particular, the Company has reviewed the nature of its larger customer relationships and is in the process of reviewing the nature of potential regional variations in all aspects of its customer base regardless of size. Based on the work performed to date, the Company expects to conduct further review and analysis of certain areas that may lead to changes in the manner in which the Company recognizes revenue, including the customized nature of the product, consignment arrangements, rebates, upfront costs, shipping terms and documentation other than formal contracts. As a result, the financial statement impact has not yet been determined. The Company continues to evaluate the potential impact of this standard on its consolidated financial statements and related disclosures. |
Accounts Receivable | Accounts Receivable The Company sells certain accounts receivable on a non-recourse basis to unrelated financial institutions under “factoring” agreements that are sponsored, solely and individually, by certain customers. The Company accounts for these transactions as sales of receivables, removes the receivables sold from its financial statements, and records cash proceeds when received by the Company. The beneficial impact on cash provided by operations from participating in these programs increased approximately $12.1 million for the nine months ended September 30, 2017 compared to an increase of approximately $25.8 million for the nine months ended September 30, 2016. The cost of participating in these programs was immaterial to our results in all periods. |
Net Income Per Share (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reconciliation of Shares Used in Computation of Basic and Diluted Net Income Per Share | A reconciliation of the shares used in the computation of basic and diluted net income per share is as follows:
|
Goodwill and Other Intangible Assets, Net (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goodwill and Intangible Assets Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Movements in Goodwill | Movements in goodwill during 2017 were as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Other Intangible Assets, Net | Other intangible assets, net consist of the following amounts:
|
Restructuring and Other Charges, Net (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Restructuring and Related Activities [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Changes in Employee-Related Restructuring Liabilities | Changes in employee-related restructuring liabilities during the nine months ended September 30, 2017, were as follows:
|
Borrowings (Tables) |
9 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2017 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Disclosure [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Components of Debt | Debt consists of the following:
(1) Amount is net of unamortized discount and debt issuance costs. |
Stock Compensation Plans (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock-Based Compensation Expense and Related Tax Benefits | Stock-based compensation expense and related tax benefits were as follows:
|
Segment Information (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reportable Segment Information | Reportable segment information is as follows:
|
Employee Benefits (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Retirement Benefits [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pension and Other Defined Contribution Retirement Plan Expenses | Pension and other defined contribution retirement plan expenses included the following components:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Postretirement Benefits Other Than Pension Expenses | Expense recognized for postretirement benefits other than pensions included the following components:
|
Financial Instruments (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investments, All Other Investments [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Carrying Amount and Estimated Fair Values of Financial Instruments | The amounts recorded in the balance sheet (carrying amount) and the estimated fair values of financial instruments at September 30, 2017 and December 31, 2016 consisted of the following:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Instruments Notional Amount Outstanding | The following table shows the notional amount of the Company’s derivative instruments outstanding as of September 30, 2017 and December 31, 2016:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Instruments Measured at Fair Value | The following tables show the Company’s derivative instruments measured at fair value (Level 2 of the fair value hierarchy), as reflected in the Consolidated Balance Sheets as of September 30, 2017 and December 31, 2016:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Instruments Which Were Not Designated as Hedging Instruments | The following table shows the effect of the Company’s derivative instruments which were not designated as hedging instruments in the Consolidated Statement of Comprehensive Income for the three and nine months ended September 30, 2017 and 2016 (in thousands):
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Instruments Designated as Cash Flow and Net Investment Hedging Instruments | The following table shows the effect of the Company’s derivative instruments designated as cash flow and net investment hedging instruments, net of tax, in the Consolidated Statements of Comprehensive Income for the three and nine months ended September 30, 2017 and 2016 (in thousands):
(1) Interest rate swaps were entered into as pre-issuance hedges. |
Accumulated Other Comprehensive Income (Loss) (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2017 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Changes in Accumulated Other Comprehensive Income (Loss) | The following tables present changes in the accumulated balances for each component of other comprehensive income, including current period other comprehensive income and reclassifications out of accumulated other comprehensive income:
* Represents a foreign currency exchange gain from the release of a currency translation adjustment upon the liquidation of a foreign entity in 2017 as disclosed in Note 1.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reclassifications of Accumulated Other Comprehensive Income to Consolidated Statement of Comprehensive Income | The following table provides details about reclassifications out of accumulated other comprehensive income to the Consolidated Statement of Comprehensive Income:
|
Net Income Per Share - Reconciliation of Shares Used in Computation of Basic and Diluted Net Income Per Share (Detail) - shares shares in Thousands |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2017 |
Sep. 30, 2016 |
Sep. 30, 2017 |
Sep. 30, 2016 |
|
Earnings Per Share [Abstract] | ||||
Basic (shares) | 79,063 | 79,580 | 79,072 | 79,727 |
Assumed dilution under stock plans (shares) | 299 | 355 | 281 | 340 |
Diluted (shares) | 79,362 | 79,935 | 79,353 | 80,067 |
Net Income Per Share - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Millions |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2017 |
Sep. 30, 2016 |
Sep. 30, 2017 |
Sep. 30, 2016 |
|
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Net income allocated to PRS | $ 0.2 | $ 0.2 | $ 0.7 | $ 0.8 |
Maximum | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Difference amount between basic and diluted net income per share | $ 0.01 | $ 0.01 | $ 0.01 | $ 0.01 |
Employee Stock Option [Member] | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Stock excluded from computation of diluted net income per share | 0 | 0 | 0 | 0 |
Stock-Settled Appreciation Rights (SARs) [Member] | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||||
Stock excluded from computation of diluted net income per share | 0 | 0 | 0 | 0 |
Goodwill and Other Intangible Assets, Net - Schedule of Movements in Goodwill (Details) $ in Thousands |
9 Months Ended |
---|---|
Sep. 30, 2017
USD ($)
| |
Goodwill [Roll Forward] | |
Balance at December 31, 2016 | $ 1,000,123 |
Acquisitions | 93,223 |
Foreign exchange | 21,784 |
Other | 38,489 |
Balance at September 30, 2017 | $ 1,153,619 |
Goodwill and Other Intangible Assets, Net - Schedule of Other Intangible Assets, Net (Detail) - USD ($) $ in Thousands |
Sep. 30, 2017 |
Dec. 31, 2016 |
---|---|---|
Finite-Lived Intangible Assets [Line Items] | ||
Total carrying value | $ 630,735 | $ 545,963 |
Total accumulated amortization | (206,597) | (180,180) |
Other intangible assets, net | 424,138 | 365,783 |
Customer relationships | ||
Finite-Lived Intangible Assets [Line Items] | ||
Total carrying value | 414,045 | 371,270 |
Total accumulated amortization | (99,300) | (82,555) |
Trade names & patents | ||
Finite-Lived Intangible Assets [Line Items] | ||
Total carrying value | 38,503 | 30,679 |
Total accumulated amortization | (14,436) | (12,198) |
Technological know-how | ||
Finite-Lived Intangible Assets [Line Items] | ||
Total carrying value | 153,410 | 119,544 |
Total accumulated amortization | (73,289) | (68,292) |
Other | ||
Finite-Lived Intangible Assets [Line Items] | ||
Total carrying value | 24,777 | 24,470 |
Total accumulated amortization | $ (19,572) | $ (17,135) |
Restructuring and Other Charges, Net - Changes in Employee-Related Restructuring Liabilities (Detail) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2017 |
Sep. 30, 2016 |
Sep. 30, 2017 |
Sep. 30, 2016 |
|
Restructuring Reserve [Roll Forward] | ||||
Additional charges (reversals), net | $ 3,249 | $ 0 | $ 14,183 | $ 0 |
Fragrance Ingredients Rationalization [Member] | ||||
Restructuring Reserve [Roll Forward] | ||||
Beginning Balance | 3,277 | |||
Additional charges (reversals), net | 14,183 | |||
Non-cash charges | (950) | |||
Payments | (10,267) | |||
Ending Balance | 6,243 | 6,243 | ||
Fragrance Ingredients Rationalization [Member] | Employee-Related Costs | ||||
Restructuring Reserve [Roll Forward] | ||||
Beginning Balance | 3,277 | |||
Additional charges (reversals), net | 13,233 | |||
Non-cash charges | 0 | |||
Payments | (10,267) | |||
Ending Balance | 6,243 | 6,243 | ||
Fragrance Ingredients Rationalization [Member] | Other | ||||
Restructuring Reserve [Roll Forward] | ||||
Beginning Balance | 0 | |||
Additional charges (reversals), net | 950 | |||
Non-cash charges | (950) | |||
Payments | 0 | |||
Ending Balance | $ 0 | $ 0 |
Goodwill and Other Intangible Assets, Net - Additional Information (Detail) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2017 |
Sep. 30, 2016 |
Sep. 30, 2017 |
Sep. 30, 2016 |
|
Goodwill and Intangible Assets Disclosure [Abstract] | ||||
Amortization of acquisition-related intangibles | $ 8,766 | $ 5,468 | $ 24,327 | $ 16,659 |
Estimated annual amortization, 2017 | 35,600 | 35,600 | ||
Estimated annual amortization, 2018 | 34,900 | 34,900 | ||
Estimated annual amortization, 2019 | 33,300 | 33,300 | ||
Estimated annual amortization, 2020 | 32,600 | 32,600 | ||
Estimated annual amortization, 2021 | 27,900 | 27,900 | ||
Estimated annual amortization, 2022 | $ 25,500 | $ 25,500 |
Income Taxes - Additional Information (Detail) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2017 |
Sep. 30, 2016 |
Sep. 30, 2017 |
Sep. 30, 2016 |
|
Spanish tax settlement | ||||
Income Taxes [Line Items] | ||||
Effective tax rate | 22.00% | 20.80% | 20.40% | 22.70% |
Foreign Tax Authority | ||||
Income Taxes [Line Items] | ||||
Provision for uncertain tax positions | $ 28.2 | $ 28.2 | ||
2007-2012 | Minimum | ||||
Income Taxes [Line Items] | ||||
Income tax examination, years under examination | 2007 | |||
2007-2012 | Maximum | ||||
Income Taxes [Line Items] | ||||
Income tax examination, years under examination | 2016 | |||
Other Liabilities | ||||
Income Taxes [Line Items] | ||||
Unrecognized tax benefits that would impact effective tax rate | 18.9 | $ 18.9 | ||
Accrued interest and penalties | 1.7 | 1.7 | ||
Other Current Liabilities | ||||
Income Taxes [Line Items] | ||||
Unrecognized tax benefits that would impact effective tax rate | 6.9 | 6.9 | ||
Accrued interest and penalties | $ 0.7 | $ 0.7 |
Stock Compensation Plans - Stock-Based Compensation Expense and Related Tax Benefits (Detail) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2017 |
Sep. 30, 2016 |
Sep. 30, 2017 |
Sep. 30, 2016 |
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Total stock-based compensation expense | $ 8,652 | $ 7,533 | $ 24,596 | $ 23,639 |
Less: tax benefit | (2,574) | (2,174) | (7,123) | (6,963) |
Total stock-based compensation expense, after tax | 6,078 | 5,359 | 17,473 | 16,676 |
Equity-based awards | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Total stock-based compensation expense | 7,256 | 5,697 | 20,149 | 19,471 |
Liability-based awards | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Total stock-based compensation expense | $ 1,396 | $ 1,836 | $ 4,447 | $ 4,168 |
Segment Information - Additional Information (Detail) $ in Millions |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2017
USD ($)
|
Sep. 30, 2016
USD ($)
|
Sep. 30, 2017
USD ($)
segment
|
Sep. 30, 2016
USD ($)
|
|
Revenues from External Customers and Long-Lived Assets [Line Items] | ||||
Number of segments | segment | 2 | |||
US | ||||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||||
Net sales | $ 251 | $ 190 | $ 731 | $ 555 |
Foreign Countries | ||||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||||
Net sales | $ 622 | $ 587 | $ 1,813 | $ 1,799 |
Sales | Foreign Countries | ||||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||||
Maximum percentage of total consolidated net sales attributed to any non-U.S. country | 10.00% |
Segment Information - Reportable Segment Information (Detail) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | |||
---|---|---|---|---|---|
Sep. 30, 2017 |
Mar. 31, 2017 |
Sep. 30, 2016 |
Sep. 30, 2017 |
Sep. 30, 2016 |
|
Net sales: | |||||
Net sales | $ 872,940 | $ 777,001 | $ 2,544,094 | $ 2,353,790 | |
Segment profit: | |||||
Restructuring and other charges, net | (3,249) | 0 | (14,183) | 0 | |
Gain on sales of fixed assets | 31 | 87 | 120 | 2,998 | |
Tax assessment | $ (5,400) | ||||
Operating profit | 157,667 | 124,426 | 454,245 | 459,032 | |
Interest expense | (19,221) | (13,111) | (49,584) | (40,649) | |
Other income, net | 2,880 | 2,075 | 17,192 | 1,954 | |
Income before taxes | 141,326 | 113,390 | 421,853 | 420,337 | |
Flavors [Member] | |||||
Net sales: | |||||
Net sales | 409,800 | 366,857 | 1,230,286 | 1,118,869 | |
Segment profit: | |||||
Operating profit | 91,378 | 77,512 | 289,723 | 259,662 | |
Fragrances [Member] | |||||
Net sales: | |||||
Net sales | 463,140 | 410,144 | 1,313,808 | 1,234,921 | |
Segment profit: | |||||
Operating profit | 93,528 | 85,010 | 260,085 | 261,843 | |
Global expenses [Member] | |||||
Segment profit: | |||||
Operating profit | (17,598) | (11,405) | (47,193) | (37,544) | |
Corporate and Other [Member] | |||||
Segment profit: | |||||
Restructuring and other charges, net | (3,249) | (190) | (14,183) | (473) | |
Acquisition and related costs | (5,436) | (786) | (20,502) | (2,035) | |
Operational improvement initiative costs | (407) | (802) | (1,473) | (1,901) | |
Legal charge | 0 | (25,000) | (1,000) | (23,518) | |
Gain on sales of fixed assets | 31 | 87 | 120 | 2,998 | |
Tax assessment | 0 | 0 | (5,331) | 0 | |
Integration-related costs | (580) | 0 | (2,501) | 0 | |
FDA mandated product recall | $ 0 | $ 0 | $ (3,500) | $ 0 |
Employee Benefits - Postretirement Benefits Other Than Pension Expenses (Detail) - Defined Contribution and Other Retirement Plans [Member] - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2017 |
Sep. 30, 2016 |
Sep. 30, 2017 |
Sep. 30, 2016 |
|
Defined Benefit Plan Disclosure [Line Items] | ||||
Service cost for benefits earned | $ 221 | $ 214 | $ 663 | $ 644 |
Interest cost on projected benefit obligation | 588 | 787 | 1,764 | 2,360 |
Net amortization and deferrals | (1,046) | (1,355) | (3,138) | (4,065) |
Net periodic benefit (income) cost | $ (237) | $ (354) | $ (711) | $ (1,061) |
Financial Instruments - Additional Information (Detail) € in Millions |
3 Months Ended | 9 Months Ended | |||
---|---|---|---|---|---|
May 18, 2017
EUR (€)
|
Sep. 30, 2017
EUR (€)
contract
|
Sep. 30, 2017
USD ($)
contract
|
Sep. 30, 2017
USD ($)
contract
|
Sep. 30, 2016
swap
|
|
Derivative [Line Items] | |||||
Derivative losses included in AOCI | $ 5,400,000 | ||||
Net investment hedge ineffectiveness | 0 | $ 0 | |||
Cash flow hedge ineffectiveness | $ 0 | $ 0 | |||
Foreign Exchange Forward [Member] | |||||
Derivative [Line Items] | |||||
Term of derivative | 12 months | ||||
Interest rate swaps [Member] | |||||
Derivative [Line Items] | |||||
Number of derivatives (swap) | swap | 2 | ||||
Number of instruments terminated (swap) | swap | 2 | ||||
Loss on settlement of derivatives | € (5.3) | € (2.9) | $ 3,200,000 | ||
Net Investment Hedging [Member] | Designated as Hedging Instrument [Member] | Foreign Exchange Forward [Member] | |||||
Derivative [Line Items] | |||||
Remaining maturity term | 1 year | ||||
Number of derivatives matured (contract) | contract | 14 | 14 | 14 |
Financial Instruments - Derivative Instruments Notional Amount Outstanding (Detail) - USD ($) $ in Thousands |
Sep. 30, 2017 |
Dec. 31, 2016 |
---|---|---|
Foreign currency contracts [Member] | ||
Schedule Of Information By Major Category Of Credit Derivatives Contracts [Line Items] | ||
Derivative instruments outstanding | $ 756,631 | $ 527,500 |
Interest rate swaps [Member] | ||
Schedule Of Information By Major Category Of Credit Derivatives Contracts [Line Items] | ||
Derivative instruments outstanding | $ 150,000 | $ 412,500 |
Financial Instruments - Derivative Instruments Measured at Fair Value (Detail) - USD ($) $ in Thousands |
Sep. 30, 2017 |
Dec. 31, 2016 |
|||||
---|---|---|---|---|---|---|---|
Derivatives, Fair Value [Line Items] | |||||||
Total Fair Value, Derivative Assets | [1] | $ 15,506 | $ 21,837 | ||||
Total Fair Value, Derivative Liabilities | [2] | 12,562 | 2,980 | ||||
Foreign currency contracts [Member] | |||||||
Derivatives, Fair Value [Line Items] | |||||||
Total Fair Value, Derivative Assets | [1] | 15,506 | 21,502 | ||||
Total Fair Value, Derivative Liabilities | [2] | 11,958 | 2,255 | ||||
Interest rate swaps [Member] | |||||||
Derivatives, Fair Value [Line Items] | |||||||
Total Fair Value, Derivative Assets | [1] | 335 | |||||
Total Fair Value, Derivative Liabilities | 604 | 725 | |||||
Fair Value of Derivatives Designated as Hedging Instruments [Member] | |||||||
Derivatives, Fair Value [Line Items] | |||||||
Total Fair Value, Derivative Assets | [1] | 1,171 | 14,100 | ||||
Total Fair Value, Derivative Liabilities | [2] | 10,546 | 771 | ||||
Fair Value of Derivatives Designated as Hedging Instruments [Member] | Foreign currency contracts [Member] | |||||||
Derivatives, Fair Value [Line Items] | |||||||
Total Fair Value, Derivative Assets | [1] | 1,171 | 13,765 | ||||
Total Fair Value, Derivative Liabilities | [2] | 9,942 | 46 | ||||
Fair Value of Derivatives Designated as Hedging Instruments [Member] | Interest rate swaps [Member] | |||||||
Derivatives, Fair Value [Line Items] | |||||||
Total Fair Value, Derivative Assets | [1] | 335 | |||||
Total Fair Value, Derivative Liabilities | 604 | 725 | |||||
Fair Value of Derivatives Not Designated as Hedging Instruments [Member] | |||||||
Derivatives, Fair Value [Line Items] | |||||||
Total Fair Value, Derivative Assets | [1] | 14,335 | 7,737 | ||||
Total Fair Value, Derivative Liabilities | [2] | 2,016 | 2,209 | ||||
Fair Value of Derivatives Not Designated as Hedging Instruments [Member] | Foreign currency contracts [Member] | |||||||
Derivatives, Fair Value [Line Items] | |||||||
Total Fair Value, Derivative Assets | [1] | 14,335 | 7,737 | ||||
Total Fair Value, Derivative Liabilities | [2] | $ 2,016 | 2,209 | ||||
Fair Value of Derivatives Not Designated as Hedging Instruments [Member] | Interest rate swaps [Member] | |||||||
Derivatives, Fair Value [Line Items] | |||||||
Total Fair Value, Derivative Assets | [1] | $ 0 | |||||
|
Financial Instruments - Derivative Instruments Which Were Not Designated as Hedging Instruments (Detail) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2017 |
Sep. 30, 2016 |
Sep. 30, 2017 |
Sep. 30, 2016 |
|
Not Designated as Hedging Instrument [Member] | Foreign currency contracts [Member] | Other income (expense), net [Member] | ||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||
Amount of (Loss) Gain Recognized in Income on Derivative | $ 4,024 | $ (3,313) | $ (9,157) | $ (6,860) |
Financial Instruments - Derivative Instruments Designated as Cash Flow and Net Investment Hedging Instruments (Detail) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | |||||
---|---|---|---|---|---|---|---|
Sep. 30, 2017 |
Sep. 30, 2016 |
Sep. 30, 2017 |
Sep. 30, 2016 |
||||
Derivative Instruments, Gain (Loss) [Line Items] | |||||||
Amount of (Loss) Gain Recognized in OCI on Derivative (Effective Portion) | $ (17,004) | $ (2,811) | $ (64,840) | $ (3,024) | |||
Amount of (Loss) Gain Reclassified from Accumulated OCI into Income (Effective Portion) | 1,599 | (715) | 3,489 | 4,380 | |||
Foreign currency contracts [Member] | Derivatives in Cash Flow Hedging Relationships [Member] | |||||||
Derivative Instruments, Gain (Loss) [Line Items] | |||||||
Amount of (Loss) Gain Recognized in OCI on Derivative (Effective Portion) | (4,229) | 98 | (4,027) | (2,830) | |||
Foreign currency contracts [Member] | Derivatives in Net Investment Hedging Relationships [Member] | |||||||
Derivative Instruments, Gain (Loss) [Line Items] | |||||||
Amount of (Loss) Gain Recognized in OCI on Derivative (Effective Portion) | (1,130) | (224) | (4,258) | (694) | |||
Foreign currency contracts [Member] | Cost of goods sold [Member] | Derivatives in Cash Flow Hedging Relationships [Member] | |||||||
Derivative Instruments, Gain (Loss) [Line Items] | |||||||
Amount of (Loss) Gain Reclassified from Accumulated OCI into Income (Effective Portion) | 1,815 | (544) | 4,062 | 4,808 | |||
Interest rate swaps [Member] | Derivatives in Cash Flow Hedging Relationships [Member] | |||||||
Derivative Instruments, Gain (Loss) [Line Items] | |||||||
Amount of (Loss) Gain Recognized in OCI on Derivative (Effective Portion) | [1] | 216 | 171 | ||||
Interest rate swaps [Member] | Interest expense [Member] | Derivatives in Cash Flow Hedging Relationships [Member] | |||||||
Derivative Instruments, Gain (Loss) [Line Items] | |||||||
Amount of (Loss) Gain Reclassified from Accumulated OCI into Income (Effective Portion) | [1] | (216) | (171) | (573) | (428) | ||
Senior Notes 2016 | Derivatives in Net Investment Hedging Relationships [Member] | |||||||
Derivative Instruments, Gain (Loss) [Line Items] | |||||||
Amount of (Loss) Gain Recognized in OCI on Derivative (Effective Portion) | $ (11,861) | $ (2,856) | (43,050) | 6,793 | |||
Currency Swap [Member] | Derivatives in Cash Flow Hedging Relationships [Member] | |||||||
Derivative Instruments, Gain (Loss) [Line Items] | |||||||
Amount of (Loss) Gain Recognized in OCI on Derivative (Effective Portion) | $ (13,505) | $ (6,293) | |||||
|
Accumulated Other Comprehensive Income (Loss) - Schedule of Changes in Accumulated Other Comprehensive Income (Loss) (Detail) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2017 |
Sep. 30, 2016 |
Sep. 30, 2017 |
Sep. 30, 2016 |
|
Accumulated Other Comprehensive Income (Loss) [Roll Forward] | ||||
Accumulated other comprehensive loss (income), net of tax, beginning balance | $ (680,095) | $ (613,440) | ||
OCI before reclassifications | 27,979 | (1,546) | ||
Amounts reclassified from AOCI | (4,535) | 3,339 | ||
Net current period other comprehensive income (loss) | $ 19,550 | $ (3,337) | 23,444 | 1,793 |
Accumulated other comprehensive loss (income), net of tax, ending balance | (656,651) | (611,647) | (656,651) | (611,647) |
Accumulated Translation Adjustment [Member] | ||||
Accumulated Other Comprehensive Income (Loss) [Roll Forward] | ||||
Accumulated other comprehensive loss (income), net of tax, beginning balance | (352,025) | (297,499) | ||
OCI before reclassifications | 42,023 | 3,198 | ||
Amounts reclassified from AOCI | (12,214) | 0 | ||
Net current period other comprehensive income (loss) | 29,809 | 3,198 | ||
Accumulated other comprehensive loss (income), net of tax, ending balance | (322,216) | (294,301) | (322,216) | (294,301) |
Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member] | ||||
Accumulated Other Comprehensive Income (Loss) [Roll Forward] | ||||
Accumulated other comprehensive loss (income), net of tax, beginning balance | 7,604 | 9,401 | ||
OCI before reclassifications | (14,044) | (4,744) | ||
Amounts reclassified from AOCI | (3,489) | (4,380) | ||
Net current period other comprehensive income (loss) | (17,533) | (9,124) | ||
Accumulated other comprehensive loss (income), net of tax, ending balance | (9,929) | 277 | (9,929) | 277 |
Accumulated Defined Benefit Plans Adjustment [Member] | ||||
Accumulated Other Comprehensive Income (Loss) [Roll Forward] | ||||
Accumulated other comprehensive loss (income), net of tax, beginning balance | (335,674) | (325,342) | ||
OCI before reclassifications | 0 | 0 | ||
Amounts reclassified from AOCI | 11,168 | 7,719 | ||
Net current period other comprehensive income (loss) | 11,168 | 7,719 | ||
Accumulated other comprehensive loss (income), net of tax, ending balance | $ (324,506) | $ (317,623) | $ (324,506) | $ (317,623) |
Accumulated Other Comprehensive Income (Loss) - Reclassifications of Accumulated Other Comprehensive Income to Consolidated Statement of Comprehensive Income (Detail) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | |||||
---|---|---|---|---|---|---|---|
Sep. 30, 2017 |
Sep. 30, 2016 |
Sep. 30, 2017 |
Sep. 30, 2016 |
||||
Schedule Of Reclassification Of Accumulated Other Comprehensive Income Loss [Line Items] | |||||||
(Losses) gains on derivatives qualifying as hedges, net of tax | $ 3,489 | $ 4,380 | |||||
Prior service cost | [1] | 5,304 | 5,602 | ||||
Actuarial losses | [1] | (20,097) | (15,434) | ||||
(Losses) gains on pension and postretirement liability adjustments, net of tax | $ (3,845) | $ (2,586) | (11,168) | (7,719) | |||
Cost of goods sold [Member] | Foreign currency contracts [Member] | |||||||
Schedule Of Reclassification Of Accumulated Other Comprehensive Income Loss [Line Items] | |||||||
(Losses) gains on derivatives qualifying as hedges | 4,642 | 5,495 | |||||
Interest expense [Member] | Interest rate swaps [Member] | |||||||
Schedule Of Reclassification Of Accumulated Other Comprehensive Income Loss [Line Items] | |||||||
(Losses) gains on derivatives qualifying as hedges | (573) | (428) | |||||
Provision for income taxes [Member] | |||||||
Schedule Of Reclassification Of Accumulated Other Comprehensive Income Loss [Line Items] | |||||||
Provision for income taxes for (Losses) gains on derivatives qualifying as hedges | (580) | (687) | |||||
Provision for income taxes for gains (Losses) on pension and postretirement liability adjustments | $ 3,625 | $ 2,113 | |||||
|
Commitments and Contingencies - Additional Information (Detail) |
3 Months Ended | 9 Months Ended | 12 Months Ended | |
---|---|---|---|---|
Sep. 30, 2017
USD ($)
Facility
|
Mar. 31, 2017
USD ($)
|
Sep. 30, 2017
USD ($)
Facility
property
|
Dec. 31, 2016
USD ($)
|
|
Commitments And Contingencies [Line Items] | ||||
Bank guarantees related to appeals on income tax and indirect tax cases | $ 16,300,000 | |||
Line of credit facility, maximum borrowing capacity | $ 950,000,000 | 950,000,000 | ||
Available lines of credit | 75,600,000 | $ 75,600,000 | ||
Duration as potentially responsible party, years | 20 years | |||
Number of facilities under potentially responsible party investigation | property | 8 | |||
Property, Plant and Equipment, Net | 828,592,000 | $ 828,592,000 | $ 775,716,000 | |
Bank guarantees and pledged assets to pursue defenses related to other contingencies | 31,900,000 | |||
Bank guarantees and standby letters of credit [Member] | ||||
Commitments And Contingencies [Line Items] | ||||
Bank guarantees and letters of credit outstanding | 38,100,000 | |||
Pledged assets [Member] | ||||
Commitments And Contingencies [Line Items] | ||||
The amount of pledged assets, principally PP&E to cover income tax and indirect tax assessments | 15,600,000 | |||
Reserve for Environmental Costs [Member] | ||||
Commitments And Contingencies [Line Items] | ||||
Estimation of possible loss | 5,000,000 | 5,000,000 | ||
Damages from Product Defects [Member] | ||||
Commitments And Contingencies [Line Items] | ||||
Additional litigation reserve | 5,300,000 | 5,300,000 | ||
Product liability | 3,500,000 | $ 1,800,000 | ||
CHINA | ||||
Commitments And Contingencies [Line Items] | ||||
Property, Plant and Equipment, Net | $ 145,000,000 | $ 145,000,000 | ||
Number of facilities | Facility | 6 | 6 | ||
Number of facilities under construction | Facility | 2 | 2 | ||
Guangzhou Flavors Plant [Member] | CHINA | ||||
Commitments And Contingencies [Line Items] | ||||
Property, Plant and Equipment, Net | $ 68,000,000 | $ 68,000,000 | ||
Zhejiang Ingredients Plant [Member] | CHINA | ||||
Commitments And Contingencies [Line Items] | ||||
Property, Plant and Equipment, Net | 25,000,000 | $ 25,000,000 | ||
Minimum | ||||
Commitments And Contingencies [Line Items] | ||||
Estimation of possible loss | 0 | |||
Minimum | Zhejiang Ingredients Plant [Member] | CHINA | ||||
Commitments And Contingencies [Line Items] | ||||
Restructuring, accelerated depreciation of fixed assets | 0 | |||
Maximum | ||||
Commitments And Contingencies [Line Items] | ||||
Estimation of possible loss | 23,000,000 | |||
Maximum | Zhejiang Ingredients Plant [Member] | CHINA | ||||
Commitments And Contingencies [Line Items] | ||||
Restructuring, accelerated depreciation of fixed assets | $ 12,000,000 | |||
ZoomEssence [Member] | ||||
Commitments And Contingencies [Line Items] | ||||
Payments for legal settlements | 56,000,000 | |||
Additional payments for legal settlements | $ 1,000,000 |